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During the last decades, several cholera pandemics have taken place. Still, cholera currently
continues to be a major cause of morbidity and mortality making it a worldwide health
problem. The causative agent of the disease is the bacterium V ibrio cholerae, and the
toxin responsible for the symptoms is called cholera toxin (CT). CT is an AB5 hexameric
enterotoxin consisting of two non-covalently bound parts: A and B subunits. The A subunit
is responsible for the toxicity functions of CT while the B-pentamer is responsible for the
binding of CT to the plasma membrane (PM) in the intestinal lumen of human body. The
B-pentamer has been found to tether to GM1 gangliosides in the lipid rafts in PM. One way
to investigate these kinds of events is to use fluorescence spectroscopy, where fluorescent
markers, such as BODIPY dyes, are employed.
In this study, we investigate the effect of the composition of lipid bilayers on the
binding of CT. For this purpose, we employ atomic-scale molecular dynamics simulations
for a total of 2.8 microseconds. We consider two different lipid environments: a bilayer
consisting of DOPC (1,2-dioleoyl-sn-glycero-3-phosphocholine) in a liquid-disordered phase
(ld) and a bilayer consisting of SSM (N-stearoyl-d-erythro-sphingosylphosphorylcholine)
and cholesterol in a liquid-ordered phase (lo). These membranes are enriched with both the
native GM1 and the BODIPY-labeled GM1 resulting in four different lipid environments.
In addition to four 500-nanosecond simulations of these membranes in the presence of the
protein we also study the same four systems for 200 nanoseconds without the B-pentamer,
this case serving as a reference.
The results show that cholera toxin binds rapidly to all simulated membranes. However,
membrane properties important to the toxin binding were noticed to be dependent on the
composition of the lipid bilayer. Electrostatic potential was observed to change significantly
between the ld and lo phases. Also the geometry of the head group of GM1, essential
for the receptor–ligand fitting, was noticed to change as the composition of the bilayer
was altered. The results support the idea of CT binding to the GM1 ganglioside, and the
membrane in the ld phase was noticed to be the most favorable for the toxin binding.
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Viimeisten vuosisatojen aikana on esiintynyt useita kolerapandemioita. Silti kolera on
edelleen maailmanlaajuinen terveysongelma aiheuttaen runsaasti sairastumisia ja kuolemia
vuosittain. Koleran aiheuttaa V ibrio cholerae -bakteerin eritta¨ma¨ koleratoksiini. Se on
heksameerinen (AB5) enterotoksiini, joka koostuu ei-kovalenttisesti toisiinsa sitoutuneista A-
ja B-alayksiko¨sta¨. A-alayksikko¨ on koleratoksiinin myrkyllinen osa, kun taas B-pentameeri
vastaa proteiinin sitoutumisesta solukalvoon ihmisen suolistossa. Kokeissa B-pentameerin
on havaittu sitoutuvan solukalvon GM1-reseptoreihin. Na¨issa¨ mittauksissa fluoresens-
sispektroskopia on usein ka¨ytetty menetelma¨, jolloin fluoresoivat merkkiaineet, kuten
BODIPY, ovat tarvittavia apuva¨lineita¨.
Ta¨ssa¨ tyo¨ssa¨ tutkittiin kuinka lipidikoostumus ja lipidien ja¨rjesta¨ytyminen solukal-
vossa vaikuttavat koleratoksiinin sitoutumiseen. Ta¨ta¨ varten simuloitiin yhteensa¨ 2.8
mikrosekuntia atomitason molekyylidynamiikkasimulaatioita. Tutkimuksessa rakennettiin
kaksi erilaista lipidiympa¨risto¨a¨, joista toinen mallinsi epa¨ja¨rjesta¨ytynytta¨ kalvoa koostuen
DOPC-lipideista¨, ja toinen ja¨rjestynytta¨ kalvoa koostuen SSM-lipideista¨ ja kolesterolista.
Molempiin kalvoihin lisa¨ttiin seka¨ tavallista GM1-molekyylia¨ etta¨ BODIPY:lla¨ muokattua
GM1-molekyylia¨ niin, etta¨ yhteensa¨ tutkittavia solukalvoja saatiin nelja¨ kappaletta. Kaikkia
kalvoja simuloitiin koleratoksiinin la¨sna¨ollessa 500 nanosekuntia, ja referenssisysteemeiksi
samoja kalvoja ilman proteiinia 200 nanosekuntia.
Tutkimuksessa havaittiin, etta¨ koleratoksiini sitoutui nopeasti kaikkiin tutkittuihin
solukalvoihin. Proteiinin sitoutumiselle ta¨rkeiden solukalvon ominaisuuksien huomattiin
kuitenkin vaihtelevan lipidikompositiota muutettaessa. Solukalvon elektrostaattisen potenti-
aalin havaittiin muuttuvan, kun epa¨ja¨rjestyneesta¨ faasista siirryttiin ja¨rjestyneeseen. Ta¨ma¨n
lisa¨ksi myo¨s GM1-reseptorin pa¨a¨ryhma¨n geometrian huomattiin muuttuvan solukalvon
kompositiota muutettaessa. Tulokset tukevat aiemmin esitettya¨ ajatusta siita¨, etta¨ kolera-
toksiini sitoutuu GM1-gangliosidiin ja sitoutuminen on suotuisampaa epa¨ja¨rjestyneeseen
kalvoon.
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11. INTRODUCTION
Seven acknowledged cholera pandemics have taken place during the last decades [1].
Cholera still continues to be a major cause of morbidity and mortality making it a
worldwide health problem. As many as 3–5 million cases and 120,000 deaths are
recorded every year [2]. The disease is contracted through ingestion of contaminated
food or water, which makes it a major problem in developing countries, where access
to safe food and water and sufficient sanitation cannot be assured for all. Cholera is
characterized by profuse diarrhea and vomiting, which leads to a loss of body fluids
and dehydration. Without prompt attempt to treat the patient, the disease becomes
fatal in most cases.
The causative agent of the disease is the bacterium V ibrio cholerae, and the
responsible toxin for the symptoms is cholera toxin (CT). CT is a hexameric AB5
enterotoxin consisting of two amino acid sequences, A and B subunits. The A subunit
(CTA) is responsible for the toxicity of CT. It catalyzes adenosine diphosphate
(ADP) ribosylation of the α subunit of the guanosine triphosphate (GTP) binding
protein. This leads to activation of adenylate cyclase which increases the level of
cyclic adenosine monophosphate (cAMP), causing the secretion of ions and water
into the intestinal lumen of human body. The B subunit (CTB or B-pentamer)
consists of five tightly packed B monomers. The B-pentamer is responsible for the
toxin binding and it is considered as a molecular recognition unit and delivery vehicle
for the A subunit [3, 4]. It has been noticed that the CTB has a high affinity to
GM1 ganglioside receptor, which is found in the outer leaflet of plasma membranes
of virtually all cell types [3].
In addition to the research of new drugs against cholera, B-pentamer is also used
in other studies such as investigation of membrane properties [5, 6]. In that field,
fluorescence spectroscopy is a commonly used method. Furthermore, fluorescent
probes are often required in these studies. Lots of different fluorophores are known
and the BODIPY fluorophore family is one of them. It has gained popularity because
of its excellent properties as a fluorescent probe [7].
In general, the data obtained from experiments is often affected by the perturbation
caused by fluctuations in the experiments or the applied methodology itself. Also,
the needed resolution to examine interactions and structural properties is often
limited. The idea for this study originates from experimental studies which showed
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that the affinity of cholera toxins to a membrane varies when the lipid packing is
altered. Additionally, it has been suggested that the BODIPY fluorophore used in
the experiments as a marker for the GM1 receptor perturbates the toxin binding
process.
Due to poor resolution in experiments, the aim of this thesis was to study through
atomistic molecular dynamics simulations how the changing of the lipid composition
of a protein-free membrane affects the binding of cholera toxin. For this purpose,
a total of 8 different systems were simulated. Both the membrane in the liquid-
disordered phase (consisting of DOPC) and the membrane in the liquid-ordered
phase (consisting of 1:1 SSM and cholesterol) were enriched with the native GM1
and BODIPY-labelled GM1 molecules, resulting in four different membranes. The
membranes in the presence of the B-pentamer were simulated for 500 ns, and the
membranes in the absence of CTB for 200 ns as a reference.
This thesis is divided into seven chapters. The next chapter focuses on the
biological background relevant to this study, describing the nature of the cholera
disease. Causative organism of the disease and the most important toxin secreted
by the bacterium are discussed in more detail. The third chapter provides basic
knowledge about the fluorescence phenomenon and how it can be used in experimental
measurements. The fourth chapter concentrates on the principles of the classical
molecular dynamics method used in this study, with an emphasis on the force field
and the ensembles used to describe the physical conditions. The fifth chapter is
dedicated to the simulated systems describing the initial configurations as well as
the parameters applied in the simulations. The sixth chapter contains the results
obtained from the simulations and discusses their meaning in a biological framework.
Finally, the seventh chapter summarizes the results along with an outlook for future
research.
32. BIOLOGICAL BACKGROUND
In this chapter the background relevant to this study is discussed. First, the nature
of the cholera disease is given with a short history about it. Second, the causative
organism of the disease, V ibrio Cholerae, is presented. Next, the bacterial toxins are
reviewed in general. The chapter is closed with a discussion about the responsible
toxin for the symptoms, cholera toxin. The information in this chapter is based on a
few books [8–10] and review papers [4, 11, 12].
2.1 Overview of Cholera
Cholera is a disease which begins with a sudden onset of massive diarrhea accompanied
by a loss of a large amount of protein-free fluid along with electrolytes and ions. In
addition to diarrhea and vomiting, a hypovolemic shock and acidosis are characteristic
symptoms of the disease. Without prompt attention to treat the patient, the resulting
hydration produces tachycardia, hypotension and vascular collapse. Under such severe
conditions the disease becomes fatal in most cases.
2.1.1 History of Cholera
The etymology of the term “cholera” is not totally clear. It was first seen in the works
of Hippocrates and believed to have been derived from the Greek words chole (bile)
and rein (to flow), thus meaning the flow of bile [13]. Afterwards, there have been
many other suggestions [14–16] to the origin of the name, but a generally accepted
understanding of the etymology is still missing.
Cholera often occurs in epidemics. If an epidemic lasts for many years and spreads
to many different countries and even across continents, it is usually called a pandemic.
It is generally recognized that seven distinct pandemics of cholera have occurred.
The first one took place in the 19th century in India and the last one in the mid of the
20th century, beginning in Indonesia [16]. Currently ongoing outbreaks in Zimbabwe
and Haiti are included in the seventh pandemic [17].
The purpose of this study is not to review the whole history of the disease, though
a few important discoveries made in the 1800’s and the early 1900’s are worth
of emphasizing. In the 1830’s, during the second pandemic, O’Shaughnessy first
demonstrated that the characteristic rice water stools of patients contained salts
and alkali. A few decades later, John Snow made an observation that cholera is
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transmitted through water. In the late 1800’s during the 5th pandemic, Robert Koch
managed to isolate the bacterium from the rice water stools of cholera patients [18].
At the moment, Koch named the bacterium as “comma bacilli” because of the comma
shape of the bacterium, nowadays known as V ibrio cholerae (V. cholerae).
Plenty of different types of the bacterium V. cholerae have been found. The
serogroup O1 of V. cholerae was in charge of all the first five pandemics. During the
seventh pandemic, a new biotype, El Tor, was found. Also a totally new serogroup
O139 was found in the 1990’s. Properties of the bacterium V. Cholerae will be
discussed in more detail in section 2.2.
2.1.2 Causation and Treatment of the Disease
It is known that the causative agent of cholera is the bacterium V ibrio cholerae.
Apparently, humans are the only natural hosts for the cholera vibrios. Cholera
is acquired through ingestion of water or food contaminated with the feces of an
infected human being. Usually, most of the cholera-causing vibrios die in the stomach
because of the acidic environment. However, some bacteria may survive into the
small intestine where they multiply rapidly and produce toxins. One of the toxins
secreted by V. cholerae is the cholera toxin. It causes a profuse amount of water and
electrolytes to be secreted into the bowels, to be eliminated as watery diarrhea. The
loss of a large volume of fluid and electrolytes has to be replaced to prevent kidney
failure, coma, and death.
The key to the treatment of cholera lies in preventing the dehydration. This
can be taken care of by replacing the fluids and electrolytes lost through diarrhea
and vomiting. Rehydration can be accomplished orally [19, 20], which makes the
treatment greatly simplified. The method currently being used and recommended by
the World Health Organization (WHO) is oral rehydration solution (ORS) containing
water, sugar, and salts. However, in the case of severe dehydration, treatment has to
be done intravenously. An antibiotic called tetracycline is also used to shorten the
duration of the illness and reduce the fluid loss [21].
2.2 Bacterium Vibrio Cholerae
Cells are the basic structural units of all living organisms. Bacteria are the smallest
living cells and they have a cytoplasmic membrane surrounded by a cell wall. The wall
is rigid because of a unique polymer called peptidoglycan [22]. A simple prokaryotic
cell does not include any mitochondria, lysosomes, endoplasmic reticulum, or other
organelles typical to eukaryotic cell. In fact, most bacteria are about the size of a
mitochondria. Bacteria have no nucleus, but all the chemical elements of nucleic acid
and protein synthesis are present due to a single double-stranded deoxyribonucleic
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Figure 2.1: Illustration of bacterium V ibrio cholerae. The huge flagellum, several pilis,
and the nucleoid, which contains the genome of the bacterium can be clearly
seen. Picture modified from [23].
acid (DNA) chromosome in the cytoplasm. Although the nutritional requirements
vary greatly among the bacteria, most of them are free-living if given an appropriate
energy source.
The cholera vibrios are gram-negative, slightly curved and often comma-shaped
rods with an average diameter of 0.55 µm and length of 1.8 µm (see Fig. 2.1). A
classification of V. cholerae is summarized in Table 2.1. The protoplasm of the
bacterial cell consists of an electron-transparent central zone, the nucleus, and is
surrounded by the electron-dense region of the cytoplasm. The bacterial protoplasm
of V. cholerae is bounded by the plasma membrane, which exhibits a trilamellar
structure with an overall thickness of about 7.5 nm. The outer side of the plasma
membrane has a periplasmic space thickness of 5–10 nm. The periplasmic space
is covered by another layer of membranous structure, the cell wall, which also has
a trilamellar structure with an overall thickness of about 10 nm at the outermost
periphery of the cell.
The mobility of the bacterium depends on a single polar flagellum possessed by it.
The flagellum has a core covered by a sheath. The diameters of the core and the
sheath are about 15 and 30 nm, respectively. The single polar flagellum is attached
to a structure called the basal granule, which is about 65 nm in size in the bacterial
protoplasm.
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Table 2.1: Classification of bacterium V. cholerae [10].
Type Name
Kingdom Bacteria
Phylum Proteobacteria
Class Gamma Proteobacteria
Order Vibrionales
Family V ibrionaceae
Genus V ibrio
Species V. cholerae
Binomial name V ibrio cholerae
Several different kinds of a hair-like appendage called fimbriae or pili have been
found on the surface of the bacterium. The presence of a small number of pili of
diameter 6-8 nm was first recorded on El Tor vibrios. Also an other completely
different type of pili has been detected and it has been found to be a colonization
factor of the V. cholerae serogroup O1.
2.2.1 Subtyping
To investigate V. cholerae in more detail and categorize it into different species,
sophisticated methods are needed. The following methods have proven to be useful
for classifying or characterizing the strain of V. cholerae, and they can be used
either singly or in combination: restriction fragment length polymorphism (RFLP)
of ctx genes [24, 25], RFLP analysis of ribosomal ribonucleic acid (rRNA) genes [26],
deoxyribonucleic acid (DNA) or gene probes [24, 25, 27], and multilocus enzyme
electrophoresis (MEE) or zymovar analysis [28].
Different V. cholerae species have been divided into different serogroups. The
serogrouping is performed on the basis of the heat-stable O-antigen of the bacteria.
There are already around 200 serogroups (O1 to O200) identified and more may
be found in the future. Serogroups O1 and O139 are the most important ones to
be remembered. Previously all major cholera epidemics were caused by the same
serogroup O1. In 1992 the serogroup O139 was emerged to cause an epidemic in
the Indian subcontinent. The O1 serogroup has been subdivided further into three
different serotypes and two different biotypes. Three serotypes are Inaba, Ogawa,
and Hikojima, where the names denote their historical origins. DNA sequences of
Inaba and Ogawa antigens are nearly identical. The two biotypes of O1 strains are
classical and El Tor. Subdivision is based on several tests described by Chatterjee et
al. [29]. The El Tor biotype was discovered in 1971 as the causative agent of the
seventh pandemic of cholera. A summary of different serogroups, serotypes, and
biotypes of V. cholerae is presented in Table 2.2.
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Table 2.2: Classification of V . cholerae species [10].
Serogroups Epidemic spread Serotypes Biotypes (names)
O1 High Inaba,Ogawa,Hikojima 2 (classical, El Tor)
O139 High Nil 1
Other non-O1 Low Nil 1
2.2.2 Growth Requirements and Characteristics
The nutritional requirements for cholera vibrios are rather simple. They grow in media
containing an inorganic nitrogen source, a utilisable carbohydrate, and appropriate
minerals. Vibrios can grow anaerobically, although they reach higher population
densities in the presence of aeration. They are sensitive to low pH and therefore
their growth is stimulated by the addition of NaCl (1%). Vibrio cultures are usually
grown by shaking at 37 ◦C [30].
The mechanism of division of V . cholerae is similar to that of any other gram-
negative bacterium: elongation to double the original length and then division
through a simple pinch-off process. In a favorable habitat, cholera vibrios grow
rapidly with a generation time of less than 30 minutes.
2.3 Bacterial Toxins
Bacterial toxins are usually proteins, encoded by the bacterial chromosomal genes,
plasmids, or phages. V ibrio cholerae produces several different toxins all of them
belonging to the family V ibrionaceae. In order to better understand the functions
of the bacterium V. Cholerae and one of its toxins, cholera toxin, it is useful to
get familiar with the basics of bacterial toxins in general. The different types of
toxins produced by bacterial cells are broadly classified as endotoxins, exotoxins,
and enterotoxins. A few basic properties that differentiate the endotoxins and the
exotoxins are listed in Table 2.3. Enterotoxins are a type of exotoxin released by
bacteria in the intestine. Cholera toxin is an enterotoxin.
Usually the toxins are liberated from the organism by lysis. However, some are
shed along with outer membrane proteins in vesicles. Toxins may damage or alter the
functions of the eukaryotic cell membrane. They interact with specific receptors on
the surface of the membrane and penetrate through the cell to reach their intracellular
target. Many protein toxins have an AB-structure where A denotes an enzyme that
is part of the toxin and B binds to the receptor. Toxins are activated either when
produced by the bacterium or when bound to the membrane receptor. An enzymatic
process common to many toxins is adenosine diphosphate (ADP)–ribosylation of the
adenylate cyclase regulatory proteins, leading to an increase in intracellular cyclic
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Table 2.3: General properties of typical endotoxins and exotoxins [10].
Property Endotoxin Exotoxin
Chemical nature Lipopolysaccharide Protein
Relationship to cell Part of outer membrane Extracellularly secreted
Denatured by boiling No Usually yes
Antigenic Yes Yes
Forms toxoid No Yes
Potency Relatively low Relatively high
Specificity Low degree High degree
Enzyme activity No Usually yes
Pyrogenicity Yes Occasionally
adenosine monophosphate (cAMP). Although many toxin effects caused by bacteria
have been described, only a few toxins have been identified and characterized, and
only for a few toxins their mode of action has been determined at the molecular level
[31].
Some of the toxins excreted by V. cholerae are listed below: Cholera enterotoxin or
cholera toxin (CT), Zonula occludens toxin (Zot), Accessory cholera enterotoxin (Ace),
Hemolysin/cytolysin, Shiga-like toxin (SLT), and thermostable direct hemolysin
(TDH).
2.3.1 Bacterial Endotoxins
Endotoxins refer to the lipopolysaccharide (LPS) complex associated with the outer
membranes of gram-negative bacteria regardless of whether the organism is a pathogen
or not. Most of the endotoxin remains associated with the cell wall until the bacteria
disintegrates, which means that these toxins are available for action only after
the death and lysis of the bacteria to which they belong. The LPSs are complex
amphiphilic molecules with a molecular weight of around 10 kDa. They consist of
three regions: a hydrophobic lipid A which anchors LPS to the outer membrane of
bacteria, a core polysaccharide comprising inner and outer cores, and an O-specific
polysaccharide chain that is mostly responsible for LPS immune recognition. The
structure of a bacterial endotoxin is illustrated in Fig. 2.2.
2.3.2 Bacterial Exotoxins
Exotoxins are a group of soluble proteins excreted by a microorganism, including
bacteria, algae, fungi, and protozoa. Exotoxins enter host cells and alter the cell
physiology. Both gram-negative and gram-positive bacteria can produce exotoxins.
Bacterial exotoxins possess an AB structure-function organization, in which the A
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Figure 2.2: A schematic of the structure of bacterial endotoxin.
domain represents the catalytic domain and the B-domain consists of the receptor-
binding and translocation domain. Thus, the B-domain is responsible for the transport
of the catalytic A domain into the intracellular compartment of the host cell [32].
Exotoxins may be generally classified by taking into account both their sites
and their modes of action. Extracellularly acting toxins can be further classified
according to their site of action into membrane-damaging toxins like hemolysins and
phospholipase, and non-membrane-damaging toxins like lipase and collagenase. On
the other hand, intracellularly acting toxins can be classified in accordance to their
mode of action. One subgroup consists of nonribosylating toxins like shiga toxin and
adenylate cyclase. The other consists of ADP-ribosyl transferases which promote
the breakdown of nicotinamide adenine dinucleotide (NAD) into nicotinamide and
adenine diphosphate ribose (ADPR). The binding of ADPR to various proteins
results in inactivation of the bound protein. Cholera toxin belongs into this group.
2.4 Cholera Toxin
Cholera toxin (CT, sometimes abbreviated to CTX, CTx or Ctx) is secreted by
the gram-negative bacterium V ibrio cholerae in the intestinal lumen in humans
causing the massive secretory diarrhea clinically characteristic of cholera. In 1959,
two experiments [33, 34] established that the CT is an exotoxin, and nowadays it is
known that CT belongs to the larger family of AB toxins [35]. Besides studies related
to the disease cholera, CT can also be fluorescent labelled and used to investigate for
example membrane properties [5, 6].
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2.4.1 Structure
In the experiments of Finkelstein and LoSpalluto [36, 37], two different factors with
different biological activities were indentified via purification. The first one was a
toxin termed as choleragen, now known as the cholera toxin. It was noticed to be
toxic. The second factor was noncytotoxic and was found to act as a toxoid. It was
termed choleragenoid, nowadays known as CTB, the B subunit of CT. Both the CT
and CTB were made commercially available, allowing investigators to study cholera
toxin in more detail.
A1
A2
B-pentamer
Figure 2.3: Cholera toxin as visualized in Visual Molecular Dynamics (VMD) [38]. Final
picture rendered using Tachyon ray tracing library [39]. CT can be found in
the Protein Data Bank (PDB) [40] database by its identifier 1XTC [41]. Red
color represents the A2 subunit of CT, gray the B-pentamer of CT, and blue
the A1 subunit of CT. The A1 and A2 chains are linked by a flexible loop
that contains a proteolytic cleavage site subtended by a disulphide bond [42].
A series of experiments involving gel electrophoresis and other techniques revealed
the oligomeric structure of the holotoxin CT [43–47]. Crystals of choleragen were
grown succesfully from batches of freshly isolated, isoelectrically pure cholera toxin
[48], and the three-dimensional structure of CT at 2.5 A˚ resolution was determined
by X-ray crystallography [41]. In addition, the isolated CTB subunit was also
crystallized and its structure determined independently by X-ray crystallography at a
resolution of 2.4 A˚ [49]. During extensive experimental measurements, it was noticed
that long-term storage in solution at 4 ◦C or room temperature storage resulted in
extensive isoelectric heterogenity [4, 48], and this lead into six different isoelectric
species of CT: AB5, AB4B’, AB3B’2, AB2B’3, ABB’4 and AB’5.
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Figure 2.4: B-pentamer with a B-monomer highlighted with colors describing the sec-
ondary structure of the protein. On the left, the crystal structure of CT is
shown viewed sideways with the surface of the B-subunits containing the
binding sites for their membrane receptors facing downwards. On the right
CTB is visualized from above.
Holotoxin CT consists of two amino acid sequences, A and B subunits of CT,
called CTA and CTB, respectively (see Fig. 2.3). The A subunit contains 240 amino
acids while the individual monomer of the B-pentamer contains 103 amino acids.
The amino acid sequences and secondary structures for both A and B subunits
can be found from Ref. [10]. The A subunit is partially reduced to form A1 and
A2 subunits after its arrival in the endoplasmic reticulum (ER). The A1 fragment
displays ADP-ribosyl transferase activity, and the A2 fragment mediates interaction
with the B-pentamer. The function of the B-pentamer is to bind the holotoxin to the
eukaryotic cell receptor. A single Trp residue at the position 88 in CTB being located
at the subunit interface in the native B-pentamer is a useful probe for studying CTB
assembly [50]. The roles of action of these different fragments are discussed in more
detail in section 2.4.3.
The mass of CTA is about 28 kDa. It is proteolytically cleaved by V. cholerae
between residues 192 (Arg) and 193 (Ser). The resulting residues 1–192 are called
the A1 subunit and residues 192–240 are called the A2 subunit. The 23 kDa sized A1
and the 5 kDa sized A2 are linked together by a disulphide bridge. The wedge-shaped
enzymatic A1 fragment is organized into three distinct segments. The first, A11,
containing residues 1–132 forms a compact unit comprising a mixture of α-helices
and β-strands. The residues 133–161 form an extended bridge between the compact
A11 and A13 domains, called A12. A12 acts as a molecular tether, like the A2
fragment between A1 and B subunits. The third A13 is formed from 31 residues that
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surround the disulphide bridge, linking the A1 and A2 fragments. The A2 domain
is an elongated domain, consisting of an α-helix and a part that extends through
the pore formed by the B-pentamer (see Fig. 2.3). The interaction between the A
and B subunits are almost entirely mediated by the A2 domain and the B-pentamer
pore. The A2 fragment shares an extensive interface with the enzymatic A1 chain
and the B-pentamer anchoring them together at the same time. The cleft is situated
away from the A1/A2 and A/B interfaces and is probably the binding site for both
nicotinamide adenine dinucleotide (NAD) and substrate. This enables the A1 chain
to act as both an ADP-ribosyltransferase and a NAD-glycohydrolase [51, 52]. The
A subunit is loosely held above the plane of the pentameric B subunits. The pore
in the B-pentamer is just wide enough to accommodate the A2 chain as a helix.
Stabilizing contacts between the A2 chain and the B subunits within the pore are
largely hydrophobic, with a few specific hydrogen bonds.
The B-pentamer consists of five individual B-monomers, each with a size of 103
amino acids and a mass of 11.4 kDa, which makes the pentamer to have a size of
57 kDa. The function of the B-pentamer is to bind the holotoxin to the eukaryotic
cell receptor. Each monomer has a short α-helix at the N-terminus, a long α-helix,
two three-stranded antiparallel β-sheets, and another two β-strands, illustrated in
Fig. 2.4. The overall pentamer fold consists of a closed β-barrel formed by six
antiparallel β-strands, capped by an α-helix (see Fig. 2.5). The B-pentamer has an
overall diameter of approximately 6.4 nm and a height of 4.0 nm. It is a very stable
structure stabilized by a variety of interactions. The total number of hydrogen bonds
between the B subunits and its neighboring molecules is 30 and each subunit forms
seven salt bridges. Further, the B-pentamer is stabilized by the tight interdigitation
of hydrophobic groups at the subunit interface. The inner surface, the pore of the
ring, is hydrophobic. Looking down the five-fold axis into the central pore (see Fig.
2.4), the monomeric backbones are tightly packed to form a pentamer of interlocking
subunits. The parallel α-helices gently bow inward during their course, reducing the
diameter of the pore from 1.6 nm (amino terminus) to 1.1 nm (carboxyl terminus,
the binding site). When the B-pentamer is formed by the B-monomers, the surface
area of each monomer accounts for 39 % of the total accessible surface. The most
specific contacts occur at the entrance to the central pore of the B-pentamer, while
the contacts within the pore are mainly hydrophobic and water-mediated. Only a
few contacts exist between the A1 fragment and the B-pentamer, showing that the
A2 domain functions as a linker for the A and B parts of the protein.
In many books and reviews CT is compared with heat-labile enterotoxin (LT)
from the bacterium Escherichia coli. This is due to the similar structures of CT and
LT. 75 % of the amino acid sequence in the A subunits of the toxins are the same.
In the case of the B subunit, the similarity is even larger, 77 %. The most striking
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Figure 2.5: The B-pentamer with two B-monomers highlighted with the colors based on
the secondary structure of the protein. Six adjacent β-sheets formed by two
different B-monomers can be seen.
difference between the structures of CT and LT lies at the carboxyl terminus of the
A2 chain. Whereas the last 14 residues of the A2 chain of LT form an extended chain
with a terminal loop, the A2 chain of CT remains a continuous α-helix throughout
its length [41].
2.4.2 Secretion by the Vibrios
Ever since the discovery in 1959 that cholera toxin is known to be an exotoxin
[33, 34] with a total size of about 86 kDa, it has been argued that a biomolecule
of this size cannot simply leak through the membranes of the V. cholerae. The
secretion machinery of the organism V. cholerae and the mechanism of secretion of
the CT molecule have been studied widely by biochemical, genetic, and structural
studies and is now understood as a multistage process. It involves different sets of
proteins spanning the inner and outer membranes of the bacterial cell. Two secretory
machineries take care of the CT secretion from the V. cholerae: the Sec translocase
pathway and the type II secretion system (T2SS). Both of them are composed of
multiprotein complexes, and especially the type II pathway is selective and allows
only specific proteins to be secreted.
In the first phase, the A and B subunits of CT are synthesized with attached
N-terminal signal properties [53] in the bacterial cytoplasm and translocated across
the inner membrane of the Vibrios as unfolded chains. The translocation process
is mediated by secretion machinery that constitutes a protein-conducting channel.
Among the gram-negative bacteria, the Sec translocase is the general translocase
that transports synthesized proteins across the cytoplasmic membrane in an unfolded
state [54, 55]. The Sec machinery is illustrated in Fig. 2.7 and will not be further
discussed in this thesis.
After the unfolded subunits are translocated across the inner membrane to the
periplasmic space via the Sec-dependent pathway, they are folded to form the three-
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Figure 2.6: On the left, a scanning electron microscope image of V. cholerae [56]. On
the right, another picture of bacterium V. cholerae [29].
dimensional structure of the CT subunits after the polypeptide chains are released
from the signal peptides [57]. Further, the folded subunits A and B interact with
each other assembling into the complete AB5 holotoxin [58–60]. Hirst et al. noticed
that the B-monomers assembled into oligomers with a half-time of around 1 minute,
while the half-time for toxin eﬄux from periplasm was around 13 minutes [59, 60].
The assembly of cholera toxin into AB5 complexes in the periplasm was investigated
both in vitro and in vivo [50, 61]. First the disassembly and reassembly of CT was
done in vitro by Finkelstein in 1974 [62], but in vivo investigations had difficulties
due to the complex periplasmic environment [61]. When purified B-pentamers were
denatured in acid and subsequently neutralized, the B-monomers reassembled into
stable pentameric complexes [61]. It was noticed that the B-pentamers were secreted
to the extracellular environment as efficiently as assembled holotoxins [58–60]. Based
on these observations, one could suggest that the AB5 holotoxin assembly involved
the formation of a B-pentamer, followed by association with an A subunit. Instead,
evidence of direct association of the A subunit with B subunits in intermediates has
been presented. Furthermore, the A subunit was able to accelerate the B subunit
assembly in vivo [61]. Folding of cholera toxin subunits involves the formation of
intrachain disulphide bonds in the A subunit (between Cys187 and Cys199) and in
each B subunit (between Cys9 and Cys86). Disulphide bridge (Dsb) proteins are
located in bacterial periplasm and they mediate disulphide bond formation, thus
helping accelerate the slow steps of folding of cholera toxin subunits. The function of
Dsp in a prokaryotic cell corresponds to the functions of protein disulphide isomerase
(PDI) protein in an eukaryotic cell.
The fully formed CT holotoxin is translocated through the outer membrane to
the extracellular space across the type II secretion system (T2SS) involving both
the inner and the outer membrane [63, 64]. The T2SS system is generally termed
as the Eps (Extracellular protein system). A large set of accessory proteins, the
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Figure 2.7: A schematic diagram illustrating the translocation of CTA and CTB through
the Sec translocase pathway from cytoplasm into the periplasmic space of
the V. cholerae [10].
components of T2SS, designated EpsA to EpsN, are required [63–67]. The T2SS
system can be considered to consist of three subcomplexes: inner membrane platform,
pseudopilus, and outer membrane complex. Components of each subcomplex are
listed in Table 2.4. The T2SS system is illustrated in Fig. 2.8 and summarized briefly
in the following. The cytoplasmic protein EpsE becomes associated with the inner
membrane through its interactions with the innermembrane protein EpsL. EpsM
interacts with EpsL. EpsG is proposed to generate a structure similar to type IV
pilins [68, 69], and the monomers are presumed to form a pilus-like structure which
might act as a piston to push CT through the secretin EpsD, which is the only T2SS
protein integrated into the outer membrane of V. Cholerae. EpsD forms a large
pore-like structure involving 12 subunits at the outer membrane. These are the core
proteins. Other proteins act to stabilize the Eps structure to facilitate secretion. The
minor pseudopilins EpsH, EpsI, EpsJ, and EpsK interact with the major pseudopilin
EpsG. EpsC interacts with EpsD in the outer membrane and with EpsL and EpsM
in the inner membrane.
2.4.3 Intracellular Journey
In order to produce the outpouring of intracellular fluid containing different elec-
trolytes that leads to the diarrhea typical of the disease cholera, CT must enter the
intestinal epithelial cell and reach the cytosol. There it can activate the adenylate
cyclase over a long period of time in order to produce an intracellular accumulation
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Figure 2.8: The structure of the type II secretion system (T2SS). In the center is an
assembled T2SS system and in the periphery are the structures of each com-
ponent of the T2SS system. The components of T2SS system are presented
in clockwise order: (i) cholera toxin molecule, (ii) PDZ-domain of GspC from
EpsC, (iii) the periplasmic domain of GspM from EpsM, (iv) the cyto- plasmic
domain of GspL from EpsL, (v) the cytoplasmic domain of GspL (blue) in
complex with the N1 domain of the secretion ATPase GspE EpsE (red), (vi)
the secretion ATPase GspE from EpsE, with the N1 domain removed, (vii)
the globular domain of the pseudopilin GspH from EpsH, (viii) the globular
domains of pseudopilins GspI or EpsI (purple) from EpsJ (green), (ix) the
ternary complex of GspK (light and dark blue), GspI (purple), and GspJ
(green). Their PDB identifiers are: 1LTT [70], 2I6V [71], 1UV7 [72], 1YF5
[73], 2BH1 [73], 1P9R [74], 2QV8 [75], 2RET [76], and 3CIO [77], respectively.
Figure modified from [10].
Table 2.4: Three different subcomplexes of the type II secretion system (T2SS) [10].
Subcomplex Components involved
Inner membrane platform
Membrane proteins EpsC, EpsF, EpsL, and EpsM
Secretion ATPase EpsE
Pseudopilus
Major pseudopilin EpsG
Minor pseudopilins EpsH, EpsI, EpsJ, and EpsK
Outer membrane complex
Large secretin EpsD
Pilotin EpsS
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of cyclic adenosine monophosphate (cAMP), leading to the heavy outpouring of
chloride and other electrolytes. This process takes place in several stages: 1) the
attachment of CT to the plasma membrane of epithelial cell, 2) the internalization
of CT by endocytosis, 3) retrograde trafficking of CT inside the cell to reach the
lumen of the endoplasmic reticulum (ER), 4) unfolding of the A1 fragment and its
disassembly from the holotoxin, 5) translocation of the A1 fragment to the cytosol,
and 6) reactions of the A1 fragment in cytosol, leading to the activation of the
adenylate cyclase, the opening of the chloride channel and the outpouring of the
fluid. A current model for the CT cell entry and intoxication is illustrated in Fig.
2.9. The whole journey starts by the binding of CT to the GM1 ganglioside on the
cell membrane of intestinal epithelial cells. All the stages are briefly described in the
following paragraphs except for the attachment of the CT to the plasma membrane,
which will be discussed in more detail in section 2.4.4.
Endocytosis is a mechanism by which an object gains entry into the cell. The
endocytosis mechanism may vary depending on the object. CT utilizes lipid rafts
in the endocytic mechanism when it is internalized into the cell [78, 79]. The
attachment of CT to GM1 partitions in detergent-insoluble glycosphingolipid (DIG)-
rich membranes has been demonstrated by different teams [80–83]. GM1 has been
noticed to have an ability to transport CT backwards into the Golgi and ER in an
intestinal cell. After CT has bound to the GM1 ganglioside in lipid rafts on the
plasma membrane of the host cells, the toxin enters the cell by various endocytic
mechanisms, including clathrin and caveolin-dependent, as well as caveolin and
dynamin-independent mechanisms [84–90]. This involves many different proteins,
including V- and T-SNAREs [91, 92]. Endocytosis of CT can take place by different
pathways, and these pathways can function simultaneously [93]. It has been proposed
that the CT-GM1 complex is associated with the actin cytoskeleton [94] via lipid
drafts, and that the actin cytoskeleton plays a role in the trafficking of CT from
the plasma membrane to the Golgi or the ER and in the subsequent activation of
adenylate cyclase.
Protein translocation channels exist on the endoplasmic reticulum. To get there,
CT must first undergo retrograde transport. CT is transported via a glycolipid-
dependent pathway [79] where glycolipids act as transport vehicles from the plasma
membrane to the ER. The toxin can be found in the early endosome (EE) and the
recycling endosome (RE) [95, 96]. In general, the toxins are thought to move from
the EE to the trans-Golgi network (TGN), independent of the late endosome pathway
[91, 92, 97]. CT is transported directly from the early endosome via different vesicle
dockings to the TGN [92, 98, 99], utilising actin and microtubules of the host cell
[100]. From the TGN, CT is transported to the ER via a coat protein complex I
(COPI)-independent pathway in the human intestinal [101]. It has been shown that
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Figure 2.9: An illustration of the intracellular journey of CT from the intestinal lumen
to the arising of symptoms [42].
the CT-GM1 complex might bypass the Golgi cisternae, trafficking directly to the ER
[101]. CT can also be recycled between the Golgi and the ER [101]. The A subunit
of CT harbors a specific amino acid sequence Lys-Asp-Glu-Leu (KDEL)-motif [102]
that is not essential for transport to the ER [103], but appears to allow retention in
the ER by recycling CT between ER and Golgi cisternae, and enhance interaction
with endoplasmic-reticulum-associated proteins (ERAD) for retro-translocation.
CT remains bound to GM1 after entering the ER. The A1-chain must actively be
released from the toxin complex, because even after reducing the disulphide bond
between the A and B subunits, the subunits remain folded together [104]. This
is achieved by the protein disulphide isomerase (PDI) which is a redox-dependent
chaperone within the ER lumen [105]. Chaperones are special proteins that can assist
in protein folding [106]. PDI unfolds CT [105], while Erp72 works in the opposite
direction: it maintains CT in a folded conformation [107]. The recognition between
PDI and cholera toxin is not known, but it might be initiated by a relative instability
of the fold of the A subunit [108], or by exposure of the hydrophobic C-terminal
domain of the A1-chain [109]. The PDI-A1-chain is targeted to a protein on the
ER, after which the A1-chain is released from the PDI by Ero1 oxidase [110]. The
mechanism is not fully understood, and the PDI may not be the only chaperone
responsible for unfolding of the A1-chain. Additional in vitro evidence suggests that
the Hsp70 chaperone BiP plays a major role in maintaining the A1-chain in a soluble
state [111].
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The retro-translocation of CT from within the ER to the cytosol has caused
many groups to speculate that the CT, like other ERAD substrates [112], crossed
the ER membrane through a protein-conducting channel initially thought to be
the translocon Sec61 [113, 114]. This was observed by Shmitz et al. [115] in 2000.
However, there are problems with the idea that Sec61 operates in the observed way
[109]. Other possibilities for the identity of the channel have emerged [116, 117], like
Hrd1 and gp78 forming the protein-conducting channel from ER into the cytosol
[118]. Also the idea that a channel is not required at all has been presented [119].
ERAD substrates exit the ER and enter the cytosol for ubiquitination and degra-
dation by the proteasome [106]. After getting out from the ER into the cytosol, the
A1-chain has to rapidly refold into its native, enzymatically active conformation to
be able to act and avoid rapid degradation by the 20S proteasome [108, 120]. Rapid
refolding of the chain might act as a molecular ratchet to provide the driving force for
retro-translocation [121]. However, it has been shown that the A1-chain is thermally
unstable [108, 120] and not likely to refold spontaneously. Such instability challenges
the idea of self-folding as a molecular ratchet. Another idea is that the A1-chain might
require binding to a cytosolic chaperone or other CT binding proteins to stabilize
its native conformation. Also, the lack of lysines in the A1 chain [122] may affect
on the really slow degradation after retro-translocation because lysines are the sites
for polyubiquitination [122]. Polyubiquitination is the primary motif for targeting
proteins to the proteasomes which degrade proteins. However, the proteasome can
also recognize and degrade unfolded proteins in the absence of polyubiquitination.
Thus, it is probable because of the paucity of lysines in the A1 chain together with
its ability to refold rapidly protects the A1 chain from degradation in the cytosol
[79, 121]. Other factors must also be involved, since a mutant form of the A1 chain
with the same lysine residues undergoes retro-translocation but is rapidly degraded
by the proteasome after being ubiquitinated at the two lysine residues [123]. It is
possible that CT avoids the ubiquitination machinery due to cytosolic chaperones or
rapid refolding of the A1 chain upon entry into the cytosol [123]. A cofactor for the
enzymatic activity, ADP ribosylation factor 6 (ARF6), was found to stabilize the A1
chain and protect it from degradation by the proteasome [108, 120]. Thus, binding
of ARF6-GTP to the A1 chain restores order to the toxin, and this might explain
how the toxin avoids rapid degradation and induces toxicity.
The last step in toxin activity in cytosol is diffusion-limited, where the A1 chain
catalyzes the ADP-ribosylation of the heterotrimeric guanine nucleotide-binding
protein (G protein) to activate the adenylate cyclase (AC). Adenylate cyclase is not
directly activated by the binding of any hormone. Instead, it is stimulated by the G
protein which binds guanyl nucleotides guanosine triphosphate (GTP) or guanosine
diphosphate (GDP). Only the GTP complex of the G protein activates the adenylate
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cyclase. The AC is a transmembrane protein which passes through the membrane
12 times and the functionally important parts are located in the cytoplasm. The
cytoplasmic part consists of two regions which form a catalytic dimer which binds
ATP and is converted to cyclic AMP (cAMP). Thus, the net effect of the cholera
toxin is to cause cAMP to be produced, which stimulates mucosal cells to pump
large amounts of chloride ions into the intestinal contents by stucking the chloride
channels in the “open position” [4].
2.4.4 Binding to Plasma Membrane
The heterogeneous lipid composition of the plasma membrane (PM) has been shown
to be important for the function of CT. It is generally known that lipids are organized
into “lipid rafts”, specialized membrane microdomains rich in cholesterol and gly-
cosphingolipids (GSL) [124, 125]. They are recognized to play roles in signaling and
membrane trafficking [126, 127]. The structure of these microdomains has proven to
be difficult to obtain with conventional imaging methods due to resolution limits. It
has been revealed that a raft may be very small in size and highly dynamic, existing
for 10 to 20 ms and having a diameter of less than 20 to 50 nm [128]. By using the
Saffman-Delbru¨ck model [129], the estimated radius of the raft varies between 13
and 39 nm [130]. It is confirmed that association with raft is required for efficient
uptake at the plasma membrane [131]. The CTB subunit tethers the holotoxin to the
membrane, leading to the association of CT with lipid rafts, which are required for
toxin function [79, 80]. CT interference with cholesterol has been shown to inhibit
endocytosis and intracellular transport [81, 132].
The association of CT with lipid rafts appears to be crucial for toxicity [134]. CTB
has a high affinity for GM1 ganglioside, which is found in the outer leaflet of the
plasma membranes of virtually all cell types, including enterocytes and lymphocytes
[3, 135, 136]. Clustering of CT to GM1 ganglioside increases the efficiency of
retrograde trafficking to the ER, perhaps by stabilizing lipid raft microdomains, by
inducing membrane curvature [137], or by enhancing the affinity for GM1 binding
[138]. Interestingly it has been noticed that CT does not bind with a high affinity to
other gangliosides like it does to GM1 [3, 139, 140]. Thus, the endogenous addition
of GM1 allows immune cells to be attacked and intoxicated by CT [141].
Fishman et al. [142] showed in 1978 that five GM1 molecules on the membrane
surface are bound by the B-pentamer consisting of five identical binding sites. The
binding of GM1 to the five sites is suggested to be cooperative [143]. Merrit et al.
revealed in 1994 by utilising X-ray crystallography that each B subunit has a GM1
binding pocket. B subunits interact mainly with the terminal galactose, and to a
lesser tend with the sialic acid and N-acetylgalactosamine of GM1 [144]. Structure
determination showed that the specific portion of the cell surface receptor interacts
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Figure 2.10: A schematic picture of the interior of the cell. Figure modified from [133].
with toxin side chains.
The receptor-toxin binding interaction may be described as a “two-fingered grip”
because a large majority of interactions involve the two terminal sugars of GM1,
galactose and sialic acid, illustrated in Fig. 2.11. The galactose part plays the
role of the forefinger and sialic acid the role of the thumb when pinching an object
with a human hand. The longer Gal-GalNac terminal is fairly deeply buried in the
toxin-pentasaccharide complex while the shorter branch, the thumb, lies along the
toxin surface. The binding site against the forefinger of GM1 is notable for comprising
a complex net of hydrogen-bonding interactions tying all of the galactose hydroxyl
oxygens to the protein, either directly or via tightly associated water molecules. All
of the binding sites of AB5 holotoxin are located on the opposite side of the catalytic
A1 domain [145].
Several key residues in the B-pentamer have been found to be necessary for
receptor binding. One of them is the single tryptophan residue Trp88, shown by
chemical modification and site-directed mutagenesis studies [146–148]. Upon receptor
binding, the toxin-GM1 complex is stabilized due to a flexible loop comprising amino
acids 51-58 becoming more ordered. This is caused by hydrogen bond interactions
with the GM1 pentasaccharide [144]. Merrit et al. suggested also other residues
which may be important for the binding, like Glu11, His13, Glu51, Gln56, Gln61,
Asn90 and Lys91.
The saccharide moiety of GM1 is bound by the complete AB5 hexamer and the
mere B-pentamer but not by the monomeric B subunit [146]. Thus, the B-pentamer
is capable of target cell recognition and binding, even in the absence of the A subunit,
but actual intoxication follows only from exposure to the AB5 holotoxin.
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Figure 2.11: A schematic drawing showing the “two-fingered” grip binding of CT to the
GM1 pentasaccharides. Figure modified from [10].
2.4.5 Possible Approaches to a Structure-Based Drug Design
Based on the known structure of the CT and its binding to the cell membrane, the
sites where the inhibitor may act to inhibit the action of CT have been revealed
[149]. One is achieved by blocking the active site of A1 in a manner in which it
cannot catalyze the ADP-ribosylation reaction. The second approach to inhibit the
action of CT could be by blocking the interaction between the A2 fragment and the
B-pentamer, and thus the assembly of the holotoxin. The third approach could be
to prevent the binding of the B-pentamer to the cell surface receptor GM1.
In addition to structure-based drug design, there are other aspects which can
be used to develop new drugs against cholera. These include the synthesis of the
toxin, its assembly into the three-dimensional structure in the periplasmic space, its
secretion into the extracellular medium by the complex secretory mechanism evolved
by the bacteria, or its entry and retrograde voyage into the epithelial cell of the
host. These are just a few ideas to be mentioned. These methods provide many
opportunities to disturb the action of the toxin molecule. All these possibilities and
other methods of molecular biology enable us to design new effective methods for
inhibiting the physiological action of the toxin and thus preventing the onset of the
disease cholera.
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3. FLUORESCENCE
Luminescence is emission of light by any substance. It includes the emission of photons
from atoms excited in the course of chemical reactions, biochemical reactions, or upon
oxidation or reduction at an electrode [150]. Luminescence is formally divided into two
categories: fluorescence and phosphorescence, depending on the nature of the excited
state. However, the distinction between fluorescence and phosphorescence is not
always clear. In excited singlet states, the electron in the excited orbital is paired by
the opposite spin to the second electron in the ground-state orbital. Phosphorescence
is emission of light from triplet excited states, in which the electron in the excited
orbital has the same spin orientation as the ground-state electron. Transitions to
the ground state are forbidden and the emission rates are slow [151]. Fluorescence
is a methodology used in biotechnology, flow cytometry, medical diagnostics, DNA
sequencing, and genetic analysis, to name a few.
Fluorescence is based on the fluorescent molecules, also called fluorophores. In a
fluorophore an electron absorbs a photon from excitation light. Due to the excitation
photon, the energy level of the electron of the fluorescent particle is raised to an
excited state (see Fig. 3.1). Some of the energy is dissipated by molecular collisions
or transferred to a proximal molecule during a short excitation period. The remaining
energy is emitted as a photon to relax the electron back to the ground state. The
emitted fluorescence can be distinguished from the excitation light because the
emitted photon carries less energy, therefore having a longer wavelength and smaller
frequency than the excitation photon. The whole fluorescence process is cyclical as
the fluorophore can be repeatedly excited.
Both the excitation and emission wavelengths are specific characteristics for
each fluorophore. While these wavelengths are discrete for monatomic fluorophores,
polyatomic fluorophores exhibit broad excitation and emission spectra. The spectra
indicate the wavelengths that correspond to the minimum and maximum excitation
and emission signal intensity. This is illustrated in Fig 3.1.
The distance between the excitation and the emission peaks in a spectrum is called
the Stokes shift (see Fig. 3.1). It is a distinct characteristic of each fluorophore and a
key aspect in the detection of the emitted fluorescence in biological applications. For
fluorophores with very small Stokes shifts, the detection of the emitted fluorescence
can be difficult to distinguish from the excitation light because of the overlap of the
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Figure 3.1: On the left, illustrative diagram of the nature of the fluorescence phenomenon.
Blue arrow represents the absorbed excited photon and the red arrow the
emitted fluorescent light. On the right, shematic figure of the excitation
and emission spectra of a fluorophore. Stokes shift is marked in the picture.
Picture modiefied from [151].
excitation and the emission wavelenghts. Conversely, fluorophores with large Stokes
shifts are easy to distinguish and therefore they are preferred to the ones with small
Stokes shift.
Fluorescence techniques offer high spatial resolution reaching the limit of single
molecules. The scale of fluorescence lifetime can be as short as 10−8 to 10−10 s,
which makes fluorescence techniques really fast. However, the greatest advantage
of the techniques is their versatility [150]. Fluorescence sensing can be provided in
solid, liquid and gaseous media. All kinds of interfaces between these phases are
also able to be studied. This is due to the fluorescence reporter and the detecting
instrument which are connected via light emission. Fluorescence detection can be
made non-invasive and for sensing different targets within the living cells.
Many factors can influence fluorescence emission and detection. Fluorophore
emission can be directly influenced by interaction with other fluorescent or non-
fluorescent molecules, which can “quench” the emitted fluorescence from the excited
fluorophore. Fluorophore detection can be disturbed by high background fluorescence,
usually caused by insufficient removal of nonbound fluorescent probes. The low
fluorescence intensity can also limit the detection of the target fluorophore, especially
in the case of high background fluorescence. High-intensity excitation light or
prolonged exposure can cause the photochemical destruction of a fluorophore. This
is called photobleaching. It can be minimized by exposing the fluorophore to the
lowest possible level of excitation light intensity for the shortest length of time that
still yields an adequate signal detection.
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3.1 Fluorescent Labeling
Fluorophores can be broadly divided into two main classes: intrinsic and extrinsic
fluorophores [152]. Intrinsic fluorophores are those that occur naturally including the
aromatic amino acids, flavins, derivatives of pyridoxyl, and chlorophyll. Extrinsic
fluorophores are added to the sample to provide fluorescence or to change the spectral
properties of the sample. Extrinsic fluorophores include fluorescein, rhodamine,
dansyl, and numerous other substances.
One can compare different fluorophores by the brightness of a fluorophore which
is determined by the molar extinction coefficient and the quantum yield. The molar
extinction coefficient  is defined as the quantity of light absorbed by a fluorophore at
a given wavelength. The quantum yield Φ is the number of emitted photons divided
by the number of absorbed photons. The brightness of a fluorophore is the product
of  and Φ. Other important properties of a fluorophore include the amount of times
the fluorophore can be excited and the lifetime of the excited state.
Fluorescent labelling is the process of covalently attaching a fluorophore to another
molecule. The most commonly labelled molecules are antibodies, but other molecules,
such as proteins and nucleic acids are also used as specific probes. If a particle like a
protein or a lipid is labelled with an extrinsic fluorophore, the fluorophore is termed
as a fluorescent dye.
In order to measure membrane nanostructures, specific visualizations of lipids and
proteins are required. This can be done by adding a fluorescent label to the molecule
of interest. One of the most well-known proteins, the green fluorescent protein (GFP),
enables direct observation of proteins both in their native environment and in the
synthetic systems [153–155]. In the case of lipids, such a universal probe does not
exist. To probe the lipid environment sensitively and selectively [156], incorporation
of synthetic fluorescent analogs of native lipids into cell membranes has become a
common protocol for optical investigation of membranes. Fluorescent analogs of
cholesterol [157–160], sphingomyelin [159, 161–163], GM1 [161, 164–166], PC, and
PE [153] were used. When using extrinsic dyes, the addition of a fluorophore may
drastically affect native lipid behavior, especially if the dye contains hydrophilic
groups [153]. This has to be taken into account when dealing with lipid rafts because
they require specific structural features which allow their condensation into an ordered
domain. Correspondingly, most fluorescent raft lipid analogues do not enter the
raft-mimetic liquid-ordered phase of model membranes [153, 164, 167–170].
3.2 BODIPY Fluorophores
Compounds in the series of BODIPY fluorophores have an indacene-like structure
(see Fig. 3.2). BODIPY is a trademark of Molecular Probes Inc and refers to a family
3. Fluorescence 26
500 550 600 650 700 750
0
0.2
0.4
0.6
0.8
1
Wavelength (nm)
F
lu
or
es
ce
n
ce
E
m
is
si
on
N
B
N
F F
Figure 3.2: On the left, the molecule structure of a parent BODIPY fluorophore. On
the right, normalized emission spectra of ( ) BODIPY FL, ( ) BODIPY
R6G, ( ) BODIPY TR, ( ) BODIPY581/591, ( ) BODIPYTR, ( )
BODIPY 630/650 and ( ) BODIPY 650/665 dyes in methanol. Figure
modified from [133].
of dyes based on 4,4-difluoro-4-bora-3a,4a-diaza-s-indacene [151]. The framework can
be considered as a rigidized monomethine cyanine dye by introduction of a linking
group between the two nitrogen atoms. The resulting dipyrrometheneboron difluoride
structure is quite rigid, which leads to high fluoroscence quantum yields [171].
BODIPY fluorophores are extremely versatile with their derivatives spanning the
visible spectrum (see Fig. 3.2) [172]. Alkyl-substituted derivatives have a green,
fluorescein-like fluorescence. Substitution by conjugated units on one or both pyrrole
moieties causes extension of the conjugation of the pi-electrons occurring along the
organic backbone. The emission wavelength maxima range thus from 510 to 675 nm
(see Fig. 3.2) and even emission maximum wavelengths greater than 750 nm are
possible [171]. BODIPY molecules are also uncharged. They are insensitive to polarity
and solvent pH [150]. They possess a high molar absorbance
(
 ≈ 80000 1
cm×M
)
and a
quantum yield Φ that is approaching 100 %, even in water. The application of these
dyes is extremely versatile. Due to their relatively long lifetime, 4 ns or longer, they
are particularly useful for fluorescence polarization-based assays.
BODIPY fluorophores offer many advantages: high fluorescence quantum yields,
good solubility, and an excellent stability in thermal, chemical and photochemical
perspective. Since they are rather insensitive to environmental effects, like polarity
and pH, they are suitable as tracers in biology. They are in fact commonly used
for labelling amino acids, nucleotides, and other low molecular weight ligands [171].
Further, BODIPY has been used as a fluorescent marker attached to the GM1
ganglioside, the interest of this study [164, 165].
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4. MOLECULAR DYNAMICS
In this thesis, interactions between cholera toxin and various lipid bilayers are studied
with the aid of molecular dynamics (MD) which is often the simulation method of
choice when there are thousands of molecules in the system whose analysis requires
atomic scale accuracy [173]. In this study the GROMACS simulation package was
used [174, 175]. This chapter gives an overview of MD simulation methods based on
the user manual of GROMACS [176], as well as Refs. [177], [178], and [179].
Molecular dynamics simulations represent an approach to statistical mechanics
with the aid of computers [179]. MD simulation is a classical technique for computing
the equilibrium and transport properties of a classical many-body system [180]. For
simplicity, the system is assumed classical, meaning that quantum effects are ignored
so that the nuclear motion of the constituent particles obeys the laws of classical
mechanics. Only when considering translational or rotational motion of light atoms
like helium or light molecules like H2 or vibrational motion with a frequency larger
than kBT/h, one should consider quantum effects [177].
Experiments and MD simulations have many similarities to each other. An
experiment begins with preparing a sample one wishes to study and continues by
attaching it to a measuring instrument. Then the property of interest is measured
during a certain time interval. Exactly the same approach is followed in MD
simulations. At first, a model consisting of N particles has to be selected. Then it
will be simulated by Newton’s equations of motion for the system until the properties
of the system no longer change with time. In other words, we equilibrate the system.
After the equilibration period, the actual measurement is performed.
Experimental measurements are difficult to perform in small scales — in nanoscales
this is almost impossible. The aim of molecular dynamics is to provide a better
understanding of or to predict macroscopic phenomena observed in experiments. MD
simulations allow the study of properties which are beyond the access of experimental
techniques. MD simulations are also cheap to implement, which is the second
significant advantage of MD simulations compared to experiments. On the other
hand, the MD technique has a number of limitations which are going to be discussed
in section 4.6 in more detail.
MD simulation begins with creating the initial structure and giving the required
parameters for the system to be simulated. After this, the MD algorithm iteratively
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Figure 4.1: General MD algorithm.
computes the actions on all particles, integrates Newton’s equation of motion, and
updates the new positions and velocities for each particle [174]. These steps are then
repeated for the required number of steps. The schematic picture of MD workflow is
presented in Figure 4.1.
4.1 Initial Conditions
Before the MD simulation can be initiated, the systems need to be adequately
prepared. To prepare a system, one needs not only to construct the topology with the
description of force field, but also to set the positions and velocities of all the particles.
Because the results of the study are usually dependent on the initial conditions, this
should be done very carefully. Usually the assignment of the positions is based on
experimental findings and an established theoretical model.
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Figure 4.2: Maxwell–Boltzmann velocity distributions calculated with the temperature
of 300 K. Different colors represents different masses as: : 2u, : 3u,
and : 4u.
Starting velocities for each particle can be set by the user or they can be generated
accordingly to a Maxwell–Boltzmann distribution at a given absolute temperature T .
The distribution function has the following form:
p (vi) =
√
mi
2pikBT
exp
(
−miv
2
i
2kBT
)
, (4.1)
where mi is a mass of the particle i, kB is the Boltzmann’s constant, T is the
temperature and p is a probability as a function of velocity vi for each particle i. A
schematic picture of distributions for particles with different masses are illustrated
in Fig. 4.2.
All the MD simulations require a molecular description of the particles that are
simulated. The description is the so called topology which contains parameters
attributed to atoms and their interactions. These parameters describe physical
properties of atoms like atom type, mass and charge, as well as relations between them
like bonds, angles and dihedrals. It is important to emphasise and remember that all
the information in topology is static: it is never modified during the simulation which
means that, for example, new bonds cannot be created during the MD simulation.
After the system has been constructed, it has to be energy minimized before
starting the real simulations. Energy minimization is performed in order to eliminate
all the high-energy interactions which might cause instability in the system.
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4.2 Force Field
The force field is a set of potential functions which describe the interactions between
simulated particles by certain potential functions. Further on, the parameters in the
topology, as mentioned before, are included as constant coefficients in the potential
functions. Force fields are used to calculate forces acting on the atoms during the
run of a simulation. Two main kinds of interactions are discussed in the following
sections: bonded and non-bonded interactions. The total potential function is sum
of all the potential functions:
VTOT =Vbonded + Vnon–bonded. (4.2)
In this study, the OPLS all-atom force field was implemented [181].
4.2.1 Bonded Interactions
Bonded interactions involve atoms which are chemically attached to each other.
However, the bonded interactions include not only the interactions between two atoms
but also 3- and 4-body interactions. Generally 2-body interactions are denoted as
bond stretching, 3-body interactions as valence angle bending, and 4-body interactions
as dihedral angle rotation.
The bond stretching between two covalently bonded atoms i and j (see Fig. 4.3)
is often modelled by a harmonic term following Hooke’s law and can be described by
a harmonic potential
Vbonds =
∑
bonds
kr,ij(rij − rij,r)2, (4.3)
where kr,ij is the force constant which describes the rigidity of the bond, rij is the
distance between particles and rij,r the reference bond length value.
The valence angle is determined by the hybridization of the atomic orbitals of
three consecutively covalently bonded i, j and k atoms shown in Fig. 4.4. It provides
general information about the geometry of the molecular fragment. They can be
described by valence angle potentials which have the form of harmonic functions as
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well:
Vangles =
∑
angles
kθ,ijk(θijk − θijk,r)2, (4.4)
where kθ,ijk is the force constant, θijk is the angle between the three atoms and θijk,r
is the reference angle when j is the middle atom.
The dihedral angle is a torsional angle between four sequential bonded atoms.
There are different types of dihedrals, each described by a different potential function.
Improper dihedrals are meant to keep planar groups like aromatic rings planar. The
simplest improper dihedral potential is a harmonic potential:
Vimproper dihedrals =
∑
improper dihedrals
1
2
kω (ωijkl − ωijkl,r)2 , (4.5)
where kω is a force constant, ωijkl stands for the torsional angle and ωijkl,r for reference
angle.
Proper dihedral angles are defined according to the IUPAC/IUB convention,
where ω is the angle between the ijk and the jkl planes (see Figure 4.5). For proper
dihedrals there are two different most commonly used potential functions: periodic
or Ryckaert-Belleman potential. The form of the periodic potential function is
Vdihedrals =
∑
torsion
kω (1 + cos (nω − ωr)) , (4.6)
where n is a constant and ωr the reference torsional angle. The Ryckaert-Belleman
potential function for proper dihedrals has the following form:
Vdihedrals =
∑
torsion
5∑
i=0
Cn (cos (ω − 180◦))n , (4.7)
where Cn is a constant defined in the topology. The first three of cosine terms
of Fourier dihedrals (derived from 4.7) are used in the OPLS potential function
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[181, 182], which yields the following potential function:
Vdihedrals =
∑
torsion
(
V1
2
(1 + cosωijkl) +
V2
2
(1− cos 2ωijkl) + V3
2
(1 + cos 3ωijkl)
)
,
(4.8)
where V1, V2, and V3 are constants and ωijkl is the torsion angle.
4.2.2 Non-Bonded Interactions
The non-bonded interactions are pair-additive and centro-symmetric. They are
computed on the basis of a list of non-bonded atoms within a certain radius. The list
is called as a neighbour list. Two atoms which are connected via bonded interactions
are excluded from the list. Non-bonded interactions consist of Lennard-Jones (LJ)
or Buckingham potential and Coulomb interactions.
Repulsion and dispersion terms are combined in, for example, the LJ or the
Buckingham potential. In this study the LJ potential function was used:
VLJ =
∑
i<j
4ij
(
σ12ij
r12ij
− σ
6
ij
r6ij
)
fij, (4.9)
where ij and σij defines the reference length and the strength of non-bonded LJ
interactions which are individual for each atom pair ij, respectively. rij is the distance
between particles i and j. fij is equal to zero when there is up to two covalent
bindings between particles i and j. When there are three bonds, fij is equal to
0.5; these are so-called 1-4 interactions. In all other cases, fij gets a value of 1.
r12ij represents the steep repulsive interaction and r
6
ij the attractive van der Waals
interaction between two particles. Since van der Waals forces act within a short
range, the interaction potential is rapidly decaying. Therefore, these interactions are
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computed only for neighbour atoms within a certain cut-off radius.
The electrostatic interaction between two charged particles is described by the
classical Coulombic potential
Vcoulomb =
∑
i<j
1
4pi0
qiqj
rrij
fij, (4.10)
where qi and qj are the charges of particles i and j, 0 is the permittivity of the
vacuum, r the relative permittivity of the medium, rij the distance between two
particles and fij is the same as in the LJ potential function (4.9). Comparing to
van der Waals interactions, the Coulomb potential is a slowly decaying function.
Evaluation of these interactions for each pair increases the computational complexity
of the simulation significantly. Fast-electrostatic algorithms, such as Ewald methods
[183, 184], can be implemented in order to address this problem.
4.3 Equations of Motion
To compute the time evolution of positions and velocities for a system consisting of
N particles, the forces acting on the particles have to be calculated first. The force
Fi acting on a particle is a negative gradient of the sum of the potential functions V
defined in the force field:
Fi = −∇VTOT. (4.11)
The solving of the forces in the system is the most time consuming part of a MD
simulation, despite using efficient techniques which allow for much faster evaluation.
In order to minimize the needed computer resources, a common approach is to
calculate the forces only for a certain group of atoms that lie within the cut-off radius
for the interaction.
After the forces acting on each particle have been calculated, the motion of the
particles can be found by solving the Newton’s equations of motion:
Fi = mi
d2ri
dt2
, (4.12)
where mi is the mass and ri is the position of a particle i.
In order to calculate new positions and velocities, equations (4.11) and (4.12) are
computed simultaneously in short time steps. There are several different time integrat-
ing algorithms for that purpose [185]. The default MD integrator in GROMACS is a
commonly used leap-frog algorithm [186, 187], which produces identical trajectories
to the Verlet algorithm [188].
The leap-frog algorithm uses coordinates ri at time t and velocities vi at time
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t− ∆t
2
to update new positions and velocities by calculating forces F(t) at time t. In
practice, this means that GROMACS calculates the coordinates and the velocities to
each particle alternately. The mathematical format for the new position is
ri (t+ ∆t) = ri (t) + vi
(
t+
∆t
2
)
∆t, (4.13)
where ri and vi are place and velocity of a certain particle, t is a point in time which
is studied and ∆t is the size of time step. The mathematical formula for velocity in
the leap-frog algorithm is:
vi
(
t+
∆t
2
)
= vi
(
t− ∆t
2
)
+
Fi (t)
2mi
∆t, (4.14)
where mi is the mass of particle i and Fi is the force directed to it. Other variables
are the same is in equation (4.13).
4.4 Temperature and Pressure Coupling
In a basic MD simulation, one can study a system consisting of N particles in
volume V , while the energy of the system E is constant. This corresponds to a
microcanonical (constant-NVE) ensemble. However, this is not often the case in
real experiments where conditions like constant temperature and pressure (NpT) or
constant temperature and volume (NVT) are more often used. In order to simulate
systems in such ensembles, temperature and pressure coupling are often implemented.
One commonly used method to control the temperature in MD simulation is to
use the Berendsen weak coupling algorithm [189]. Nose´–Hoover thermostat [190, 191]
and velocity rescaling [192] schemes are also used to sustain constant temperature.
The Berendsen weak coupling algorithm can be understood as coupling the system
to an external heat bath with a given temperature T0. Comparison with the Nose´–
Hoover scheme has been discussed in detail in Ref. [193]. As a result, the temperature
difference in the Berendsen weak coupling method decays exponentially with a time
constant τ :
dT
dt
=
T0 − T
τ
. (4.15)
The strength of the coupling can be varied to adapt to user requirements, which is a
great benefit of the Berendsen method. In order to correct the kinetic energy distri-
bution, an additional stochastic term is added to the velocity rescaling thermostat
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applied in this study:
K = (K0 −K) dt
τT
+ 2
√
KK0
Nf
dW√
τT
, (4.16)
where K is the kinetic energy, Nf the number of degrees of freedom, and dW a
Wiener process. In this approach the velocities of all the particles are rescaled by a
properly chosen random factor. The velocity rescaling method has advantages over
the Berendsen thermostat and still produces a correct canonical ensemble.
In order to simulate the system at a constant pressure, pressure coupling, similar
to the temperature coupling, can be used. The Berendsen algorithm [189] is a
commonly used algorithm for this purpose. It rescales the coordinates and the box
size to sustain a given reference pressure P0 in a following way:
dP
dt
=
P0 −P
τp
. (4.17)
A scaling matrix µij given by
µij = δij − nPC∆t
3τp
βij (P0ij −Pij(t)) , (4.18)
is used, where δij is Kronecker delta (one when i and j are equal and zero otherwise),
nPC the number of steps between pressure rescaling, τp the pressure constant, β the
isothermal compressibility of the system, and P0ij the target pressure.
The Parrinello–Rahman coupling [194, 195] is used in cases where it is important
to calculate the thermodynamical properties of the system accurately. It is similar to
the Nose´–Hoover temperature coupling and in theory it gives the true NpT ensemble.
The box vectors represented by the matrix b obey the matrix equation motion
db2
dt2
= VW−1b′−1 (P−Pref) , (4.19)
where V is the volume of the box, W a matrix parameter which determines the
strength of the coupling, P and Pref the current and reference pressure, respectively.
Parrinello–Rahman and Berendsen barostats can be combined with any of the
temperature coupling methods in GROMACS and they both allow either isotropic
scaling of all dimensions or anisotropic deformations, scaling the three dimensions
separately. It must be remembered that if the simulation aims to study the ther-
modynamical properties of the system very accurately, it is reasonable to use more
sophisticated coupling algorithms than those described in this section.
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Figure 4.6: A schematic picture of PBCs in xy-plane in a three dimensional space.
4.5 Periodic Boundary Conditions
The size of the system in MD simulations is limited. In order to minimize the edge
effects, there are several ways to treat the boundaries of the simulation box. The
traditional way is to use periodic boundary conditions (PBC) where the space is
filled with identical cells containing translated copies of the system, thus forming an
infinite lattice. This is illustrated in Fig. 4.6. Therefore, if the particle crosses one
side of the simulation box, it re-enters the box from the opposite site immediately.
In this manner there are no undesired boundaries in this arrangement, though new
artifacts related to periodic conditions may occur. If the size of the box is too small
so that a particle residing near the box boundaries will experience the interactions
caused by other particles more than once, unwanted edge effects ruining the whole
data from the MD simulation might occur. Therefore, attention to the size of the
box should be paid.
4.6 Limitations of MD simulations
To be able to understand and analyze the results of MD simulations, the user should
be aware of the limitations of MD simulations. Since the MD method is based on a
number of assumptions and approximations, there are several limitations.
Firstly, MD simulations are classical which means that the motion of particles is
described by classical mechanics. Although there are corrections to the parameters of
the force field used in MD, taking into account quantum phenomena, the study of real
quantum behaviour with MD is impossible. For most atoms at normal temperatures
this is a correct approach, but there are cases when quantum phenomena play an
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important role and such systems cannot be studied by simulations based on classical
mechanics.
Secondly, there are many force fields which can be chosen. In addition, all of
them are approximate because the potential energy, determined on the basis of
rather simply assumed pair-additive potential functions, is highly approximate, yet
the simulation results depend on them. Furthermore, cut-off radii are used in the
calculation of interactions.
Moreover, the boundaries of a small system can result in edge effects. On the
other hand, by introducing PBCs one can avoid this kind of real face problems, but
especially for small systems this may bring unwanted artifacts related to periodicity.
Thus, it is important to be aware of the influence of the system size on these effects.
Finally, the computational cost of MD simulations is a challenge. If one aims
to study protein folding, hundreds of microseconds of simulation time, or even
milliseconds will be needed. Taking into account that membrane-protein systems
contain hundreds of thousands of atoms and the fact that one simulation does not
offer much of statistics, simulating these kinds of systems will cost a lot. Usually,
the simulation time has to be decided from the relation between the computational
cost and the amount of obtained data.
In conclusion, performing MD simulation is very challenging, although the basic
principles of MD are relatively simple. One has to be really careful with initial
conditions, algorithms and integrators, as well as analysis of the huge amounts of
obtained data when dealing with MD simulations.
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5. SIMULATION MODELS AND ANALYSIS
METHODS
This thesis does not include any kind of experimental measurements. Instead, MD
simulations described in the previous chapter were employed to study the binding of
cholera toxin to various kinds of lipid bilayers. The simulated systems consisting of
about 500,000 atoms are computer-intensive. It would have taken approximately 17
years to calculate each simulated system with a single core computer. Thus, all the
systems were simulated by using the computing facilities offered by the Finnish IT
Centre for Scientific Computing (CSC) and Tampere Center for Scientific Computing
(TCSC).
5.1 Systems Studied
The purpose of this study was to investigate the binding of cholera toxin to lipid
bilayers of various compositions. Cholera toxin itself consists of about 12,000 atoms.
Instead of simulating the whole holotoxin, only the binding part, B-pentamer,
involving about 8100 atoms was simulated with the lipid bilayers. This is relevant
because the CTB is responsible for the toxin binding. In addition to a smaller number
of atoms in the toxin, the system size was greatly reduced due to the smaller number
of water molecules needed in the simulation box compared to the case of simulating
the whole holotoxin.
To mimic different kinds of lipid bilayers, numerous types of lipids are needed.
To be able to choose appropriate lipids for this study, the basic knowledge of the
structure of the lipid bilayer is essential. Both the plasma membrane (PM) and
the endoplastic reticulum (ER) are formed of two layers of lipids comprised of fatty
acid chains and a head group linked together by a glycerol backbone, and proteins
embedded in the membrane. The lipids are naturally arranged in such a way that
their hydrophobic tails face each other while their hydrophilic heads are exposed to
water on the outer sides of the leaflets. An illustrative picture of a cell membrane
can be seen in Fig. 5.1.
Lipid bilayers can adopt an ordered gel-like phase, a liquid-ordered (lo) phase, or a
disordered liquid (ld) phase depending on the lipid composition and the temperature
of the system. The types of the membrane lipids strongly affect on the membrane
properties [197]. Long saturated fatty acid chains can pack together tightly, forming
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Figure 5.1: A schematic drawing of a cell membrane. Figure modified from Ref. [196]
a rigid structure, whereas kinks in the hydrocarbon chains due to unsaturated bonds
cause the bilayer structure to be much more loose and disordered [198]. Thus, the
fluidity of the lipid bilayer is greater in the ld phase. Cholesterol is known to interact
with the hydrophobic tails of other lipids, immobilizing them by restricting the
random diffusion and hardening the structure of the bilayer by increasing the order
of the lipid tails [102, 199]. Sphingomyelin has been noticed to make the bilayer
thicker and more gel-like due to its ordered structure [102]. Many membrane events
such as membrane fusion, protein sorting, and signaling are related to the phase
behavior of the membrane [106].
The chemical structures of different lipids may vary a lot although they have many
common features, such as insolubility in water. Lipids consist of either unsaturated
or saturated fatty acid chains depending on whether they contain double bonds or
not. Five types of lipids were used in our model membranes: cholesterol, GM1,
GM1-b, DOPC, and SSM. The chemical structures of all these lipids are presented
in Fig. 5.2.
Cholesterol is an amphiphilic molecule consisting of a polar hydroxyl group and
a rigid nonpolar steroid fragment consisting of four carbon rings. A stable bilayer
structure cannot be formed spontaneously with only cholesterol since the molecules
are too hydrophobic due to the sterol group. However, cholesterol plays a major role
in stiffening the membrane structure in mixed bilayers.
GM1 (Gal5-β1,3-GalNAc4-β1,4-(NeuAc3-α2,3)-Gal2-β1,4-Glc1-β1,1-Cer) is a
ganglioside composed of a glycosphingolipid with one sialic acid residue linked
on the sugar chain. Glycosphingolipid consists of a ceramide portion joined to a
oligosacharide head group. There are five sugar units in the oligosaccharide of GM1:
glucose, two galactose, N-acetylgalactosamine and N-acetylsneuraminic acid (NANA)
groups (see Fig. 5.2). Due to the sialic acid, the head group of GM1 is anionic. In
order to simulate the GM1 used in fluorescence spectroscopy, we replaced one of the
5. Simulation Models and Analysis Methods 40
Table 5.1: Simulated systems.
System CTB DOPC SSM Chol GM1 GM1-b Time (ns)
ld/GM1 1 440 0 0 40 0 500
ld/GM1-b 1 440 0 0 0 40 500
lo/GM1 1 0 220 220 40 0 500
lo/GM1-b 1 0 220 220 0 40 500
ld/GM1 ref. 0 440 0 0 40 0 200
ld/GM1-b ref. 0 440 0 0 0 40 200
lo/GM1 ref. 0 0 220 220 40 0 200
lo/GM1-b ref. 0 0 220 220 0 40 200
tails of native GM1 with a BODIPY molecule. This is illustrated in Fig. 5.2.
DOPC, or 1,2-dioleoyl-sn-glycero-3-phosphocholine, is a phospholipid which is
representative for phosphatidylcholines — a major component of biological membranes
found in every cell of the human body. DOPC consists of two oleic acid chains
joined together by a glycerol backbone which is connected to a positively charged
phosphatidylcholine (PC) head group. The oleic tail is unsaturated due to a cis-
double bond in it, creating a kink in the structure of the tail. It is also one of the
most common fatty acids found in cells.
Stearoylsphingomyelin (SSM or N-stearoyl-d-erythro-sphingosylphosphorylcholine)
belongs to a family of sphingolipids which are derivatives of sphingosine, an amino
alcohol with a long hydrocarbon tail, containing an additional fatty acid chain
attached to the sphingosine amino group. SSM consists of a ceramide backbone
joined to a phosphatidylcholine head group. Due to the hydrogen bonding caused
by the hydroxyl group in SSM and other sphingolipids, SSM is thought to have a
stabilizing effect on the membrane structure.
In this study, four different lipid bilayers of various compositions were constructed.
In order to mimic the liquid-disordered phase, a bilayer composed of DOPC lipids was
built. For the liquid-ordered phase, a 1:1 cholesterol/SSM bilayer was constructed. In
addition, both of these membranes were enriched with 9 mol-% of either native GM1
or BODIPY-labeled GM1 (GM1-b) resulting in four different lipid environments.
Additionally, all the systems were simulated without CTB on the bilayer as a reference.
Detailed compositions of all the simulated systems are shown in Table 5.1.
All the systems were prepared in a following manner. First, all the bilayers were
hydrated and salt was added in a physiological concentration of 150 mM NaCl.
In order to get the zero net charge for all the systems, 40 Na+ counterions were
added into all the systems due to the net charge of −e of each GM1 ganglioside.
These systems were simulated for 20 ns in order to equilibrate the bilayers. After
equilibration, the B-pentamer was added to the systems. The distance between the
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Figure 5.2: Molecular structures of the lipids used in this study. Carbohydrates in the
head group of GM1 and GM1-b are shown in the molecular structure of
GM1-b [159]. Molecular structures modified from Ref. [200].
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Figure 5.3: Illustrative picture of the simulated system consisting of libid bilayer in lo
phase with native GM1 and cholera toxin in 150 mM NaCl solution.
surface of the membrane and CTB was about 2 nm in each system. The coordinate
file for CTB was acquired from the Protein Data Bank under the identifier 1RF2
[201]. Initial configuration of the lo/GM1 system is illustrated in Fig 5.3.
5.2 Simulation Parameters
Before running the real simulations, energy of each system was minimized using the
steepest descent algorithm. All the actual simulations were performed under NpT
conditions. The temperatures were controlled with the v-rescale method [202] with
separate heat baths for the solute and the solvent. Reference temperatures for all
the simulated systems were set at 300 K with time constants of 0.1 ps. For pressure
coupling, the Parrinello–Rahman [194] semi-isotropic barostat was used with a time
constant of 0.2 ps. The reference pressure was set at 1 bar.
The OPLS all-atom force field [203] was used to parameterize all the molecules and
ions. For water, the TIP3P model that is compatible with the OPLS parameterization
was employed [204]. A time step of 2 fs was used for integration and all bonds were
constrained using the LINCS algorithm [205]. The simulation times for the systems
with and without the protein were 500 and 200 ns, respectively. The van der Waals
interactions were cut off at 1 nm. For the long range electrostatic interactions, the
particle-mesh Ewald (PME) [206] method was used.
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6. RESULTS AND DISCUSSION
In this study, the effect of various kinds of lipid bilayers on the binding of cholera
toxin was investigated. A total of four MD simulations were performed with similar
initial structures and equal simulation times. Additionally, the same systems were
simulated without the toxin as a reference. The systems with the toxin were simulated
for 500 ns, whereas the systems without the toxin were simulated for 200 ns. This
chapter presents the most important findings obtained from the simulations. All the
snapshots were prepared using VMD, which is a program used for visualization of
biomolecular systems [38]. All the graphs were made using MATLAB R© and LATEX.
6.1 Stability of the Protein
Simulated system requires a certain time to reach the equilibrium. In this study, the
equilibration of the protein is studied through the root mean square deviation (RMSD)
calculation, which is usually utilised to evaluate the deviation of the simulated
structure from the initial configuration over the course of a simulation. In general,
the smaller the obtained RMSD value, the smaller the deviation between the final
and the initial structure.
In order to calculate the RMSD for the protein, the GROMACS tool g_rmsd was
employed. The RMSD was calculated for the backbone of the CTB. The RMSDs of
the protein backbone for each system are plotted as a function of time in Fig. 6.1.
The RMSDs stabilize at about 0.2 A˚ in all the systems, which confirms the stable
structure of the protein. The changes on the order of 0.1 to 0.3 nm in RMSD are
acceptable and expected [207]. The result indicates that the secondary structure of
the protein is stable and unfolding events are not observed.
In addition to the root mean square deviation, also the root mean square fluc-
tuations (RMSFs) were calculated for the CTB in each system. For that purpose,
the GROMACS tool g_rmsf was utilised. The results are shown in Fig. 6.1. Some
successive residue regions which are moving more than the others can be noticed
from the graphs. In general, these groups are the loops in the protein. From the
loops in the protein, the residue numbers 1–4, 11–14, 32–36, 50–58, and 89–93 are in
the binding site of the protein, and the residue numbers 23–24, 43–46, 79–80, and
103 are in the opposite site of the protein, thus not affecting the binding. Due to the
flexibility of the loops, CTB can attach to the plasma membrane (PM) easily, by
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Figure 6.1: On the left, the root mean square displacement (RMSD) profiles of CTB and
on the right root the mean square fluctuation (RMSF) profiles of CTB in
each system during the 500 ns simulation. The different colours represents
CTB in different systems with: : ld/GM1, : ld/GM1-b, : lo/GM1,
: lo/GM1-b.
adjusting the positions of the residues to the surface of the membrane.
6.2 Binding of Cholera Toxin
During the 500 ns simulation, cholera toxin bound to all the simulated membranes.
Snapshots of the final structures are presented in Fig. 6.2. To present the binding of
CTB to the membrane in a more quantitative manner, the distances between the
center of mass (COM) of CTB and the COM of the membrane are shown in Fig. 6.3.
From all the curves one finds that the binding of CTB takes less than 100 ns. In
order to describe the binding process more specifically, further analysis will be shown
below.
6.2.1 Hydrogen Bonding
A hydrogen bond is an attractive electrostatic interaction between a polar hydrogen
atom (donor) and an electronegative atom (acceptor), such as oxygen or nitrogen. A
hydrogen bond may be formed either directly between the donor and the acceptor,
or via a water molecule. It is stronger than the van der Waals interaction, but
weaker than a covalent bond. In this study, the GROMACS tool g_hbond was
utilised to calculate the number of hydrogen bonds over the course of the simulations.
The GROMACS tool analyzes the hydrogen bonds between all possible donors and
acceptors of given groups. A distance criterion of 0.35 nm, and an angle of 30◦ as a
geometric criterion were used as operational definitions for hydrogen bonding.
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ld/GM1 ld/GM1-b
lo/GM1 lo/GM1-b
Figure 6.2: Final structures of each system after the 500 ns simulations. On the upper
row are the systems with a membrane in the liquid-disordered phase, and
on the lower row are the systems with a membrane in the liquid-ordered
phase. On the left column are the systems with native GM1, while on the
right are the systems with BODIPY-labelled GM1 lipids. In the pictures
different molecules are represented as follows: gray; CTB; red; cholesterol;
yellow; SSM; orange; GM1 or GM1-b; and brown; DOPC. The pictures are
visualized with VMD (Visual Molecular Dynamics) [38] and rendered using
the Tachyon ray tracing library [39].
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Figure 6.3: The distance in z direction between the COM of CTB and the COM of
membrane as a function of time for each system. The different colours
represent different systems as: : ld/GM1, : ld/GM1-b, : lo/GM1,
: lo/GM1-b.
The number of hydrogen bonds between CTB and GM1/GM1-b as a function of
time are depicted in Fig. 6.4. From the data shown, a few issues are worth empha-
sizing. First, there are hydrogen bonds between the cholera toxin and GM1/GM1-b
in all the simulated systems. This supports the idea presented in previous studies
(discussed in chapter 2) that the cholera toxin binds to the GM1 ganglioside, while
GM1 plays a role of a receptor in the PM and cholera toxin is its ligand. Second, a
difference in the number of hydrogen bonds in the different systems can be noticed.
However, in addition to fluctuations, also the initial configuration and stochasticity
of each system play a major role in this data, as if all the simulations were repeated,
the results might be different. For instance, if cholera toxin binds with three different
GM1 molecules in the first run, but only with one in the beginning of the second
run, the fluctuations in the number of hydrogen bonds are expected to be significant.
Furthermore, if the CTB binds only to one GM1 molecule, no matter if it attracts
more than one GM1 molecule or not, the simulation time of 500 ns does not allow five
GM1 lipids to move to the right places within the membrane as the probability for
this process is too low. Also, the binding of the protein may disturb the movement
of the lipids by binding on them, which increases the role of the used time scale. In
general, although the size of the simulated systems does not allow to simulate them
for a longer time, the phenomena described here might require longer time scales.
Nevertheless, computational resources used in this study were already state-of-the-art
at the current computational facilities.
The average number of hydrogen bonds during the interval of 300–500 ns in each
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Figure 6.4: Number of hydrogen bonds in each system: Upper left corner (ld/GM1),
upper right (ld/GM1-b), lower left (lo/GM1), and lower right (lo/GM1-b).
The different colours represents different lipids with: : cholesterol, :
DOPC, : GM1 or GM1-b, depending on the system, and : SSM.
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Table 6.1: Average number of hydrogen bonds between CTB and different lipids in each
system during the interval 300-500 ns.
ld lo
GM1 20.46 (± 3.35) 11.25 (± 2.09)
GM1-b 17.09 (± 2.64) 7.85 (± 1.97)
DOPC (with GM1) 0.53 (± 0.67) -
DOPC (with GM1-b) 4.59 (± 1.51) -
SSM (with GM1) - 2.59 (± 1.29)
SSM (with GM1-b) - 11.10 (± 1.78)
system are presented in Table 6.1. The number of hydrogen bonds between CTB
and different lipids is the highest in the case of GM1. Because the binding process
betweenCTB and GM1 was suggested before in other studies, the hydrogen bonds
between GM1 and each residue of the CTB were calculated. As can be seen from
Table 6.2, some residues of CTB play a significant role in binding, i.e. Thr1, Glu11,
His13, Lys34, Arg35, Ser55, Gln56, Asp59, Lys62, and Lys91. Out of these ten
residues, three are Lysine (Lys), one is Histidine (His), and one is Arginine (Arg),
which all have positively charged side chains. Otherwise, Glutamic acid (Glu) and
Aspartic acid (Asp) residues have negatively charged side chains. The rest of the
residues, Thr, Ser, and Gln, have a polar uncharged side chain. By looking at the
results, there are no amino acid residues which contain a hydrophobic side chain.
Furthermore, the electrostatic potential of the membrane may play a major role in
the binding process. Comparing to the residues suggested by Merrit et al. [144],
any hydrogen bonds between Glu51, Gln56, Gln61, and Asn90 residues and CTB
were not observed. Moreover, in addition to the residues mentioned by Merrit et al.,
hydrogen bonds between GM1 and many other CTB residues presented in Table 6.2
were found.
6.3 Geometry of GM1
In order to describe the geometry of GM1 and GM1-b molecules, three vectors within
the head group of GM1 were chosen and the angles between the vectors and the
membrane normal were calculated. The chosen vectors are referred to as forefinger,
thumb, and neck, and they are illustrated in Fig. 6.5 together with the reference
vector — the normal of the membrane. A more specific picture of the vectors within
the head group of GM1 is shown in Fig. 6.6.
There are only a few GM1 molecules which are bound to the toxin in all the
systems in total, and the time scale is rather short. Due to poor statistics, it is not
possible to give well-defined orientations for the different components in the head
group of GM1 while the toxin is bound to the membrane. Instead of studying only a
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Table 6.2: Average number of hydrogen bonds between the GM1 or GM1-b and each
residue of the CTB in different systems during the 300–500 ns interval.
ld/GM1 lo/GM1 ld/GM1-b lo/GM1-b
Thr1 1.342 ± 0.496 3.743 ± 1.173 0.653 ± 0.487 0.010 ± 0.099
Asp7 - - 0.020 ± 0.140 -
Ala10 - - 0.005 ± 0.070 -
Glu11 0.114 ± 0.318 0.955 ± 0.576 0.500 ± 0.888 0.089 ± 0.286
Tyr12 - 0.059 ± 0.237 0.064 ± 0.246 -
His13 0.074 ± 0.298 0.020 ± 0.140 0.772 ± 0.738 0.213 ± 0.434
Asn14 0.010 ± 0.099 0.015 ± 0.157 0.193 ± 0.432 0.634 ± 0.680
Gln16 - 0.158 ± 0.417 0.050 ± 0.218 -
Ile17 - 0.035 ± 0.183 - -
His18 - 0.010 ± 0.099 - -
Thr19 - 0.005 ± 0.070 - -
Gly33 0.015 ± 0.121 - 0.208 ± 0.407 -
Lys34 5.480 ± 1.309 2.654 ± 0.992 1.183 ± 0.583 0.965 ± 0.687
Arg35 6.817 ± 0.893 2.055 ± 0.286 2.168 ± 0.388 0.005 ± 0.070
Glu51 - - 1.698 ± 0.979 -
Pro53 0.025 ± 0.156 - - 0.005 ± 0.070
Gly54 0.059 ± 0.237 - - -
Ser55 0.985 ± 1.005 0.416 ± 0.523 0.371 ± 0.578 0.728 ± 0.952
Gln56 0.347 ± 0.606 0.718 ± 0.627 0.708 ± 0.719 0.163 ± 0.444
His57 1.084 ± 0.784 0.010 ± 0.099 0.337 ± 0.504 -
Ile58 - 0.015 ± 0.121 0.173 ± 0.379 -
Asp59 0.837 ± 0.891 0.134 ± 0.355 1.183 ± 0.632 1.619 ± 0.919
Ser60 0.020 ± 0.140 0.015 ± 0.157 - -
Gln61 - 0.015 ± 0.121 0.035 ± 0.183 -
Lys62 2.936 ± 0.847 0.015 ± 0.121 0.535 ± 0.799 1.579 ± 0.730
Lys63 - - 0.619 ± 0.778 1.787 ± 0.810
Trp88 - - 0.005 ± 0.070 -
Asn89 - 0.070 ± 0.273 0.015 ± 0.121 -
Asn90 - 0.139 ± 0.361 1.708 ± 0.697 -
Lys91 0.252 ± 0.447 0.035 ± 0.183 1.980 ± 0.919 0.030 ± 0.170
Thr92 - 0.074 ± 0.281 0.138 ± 0.387 -
His94 - 0.005 ± 0.070 - -
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Thumb
Neck
Membrane normal
Figure 6.5: An illustrative figure of the chosen vectors from the head group of GM1
and the reference vector — normal of the membrane. The different colours
represents different vectors and names as: : forefinger, : thumb, :
neck, and : membrane normal.
6. Results and Discussion 51
Table 6.3: Average angle during the 500 ns simulation.
Vector System Average angle (◦)
Forefinger ld/GM1 82.1
Forefinger ld/GM1-b 85.4
Forefinger lo/GM1 83.3
Forefinger lo/GM1-b 84.7
Thumb ld/GM1 70.6
Thumb ld/GM1-b 65.0
Thumb lo/GM1 69.5
Thumb lo/GM1-b 63.6
few lipids, the data of all the GM1 gangliosides in both leaflets and in both systems
(normal and reference) were used to calculate the orientation of the head groups of
GM1 and GM1-b. The angles between the normal of the membrane and the different
vectors were calculated separately for both leaflets so that the reference vector was
the membrane normal facing towards the water phase.
The results calculated for the systems with BODIPY-labelled GM1 are shown in
Fig. 6.6. In the histograms, more peaks can be seen in the system with the lo bilayer
compared to the bilayer in the ld phase. This makes sense due to the freedom of
movement of lipids in the ld phase which allows more flexibility to the orientation of
lipids and their head groups. On the contrary, in the lo phase the structure of the
lipids is more rigid which constraints the movement of molecules, and this may also
disturb the binding of CTB to GM1. This may decrease the probability of interaction
between the receptor and its ligand due to a favorable conformation of GM1 for the
toxin binding.
The angle distribution as a function of time for the forefinger and the thumb
vectors in the systems with the protein are shown in Fig. 6.7. The averages of the
angles after 300 ns of simulation in each system are shown in Table 6.3. A slight
increase in the angle between the normal of the membrane and the forefinger vector
is observed when native GM1 is replaced with GM1-b. However, this change is
not significant enough to make strict conclusions. Instead, the change in the angle
between the normal of the membrane and the thumb vector is more significant when
the native GM1 is replaced with the BODIPY-labelled GM1. The decrease of this
angle means that the thumb bends towards the water phase when the BODIPY
probe is attached to GM1. Due to this bending of the thumb, the binding of cholera
toxin may be distracted due to the change in geometry of the head group of GM1.
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Figure 6.6: On the left, angle distributions for the angle between the membrane normal
and the different vectors chosen from the GM1-b head group. The chosen
vectors can be seen on the right. The different colours in the graphs represent
different systems as: : the system with the membrane in the lo phase, :
the system with the membrane in the ld phase. For all the angle distributions
in the lo phase, three Gaussian fits are shown for the forefinger and the thumb,
and two fits for the neck.
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Figure 6.7: Angle distributions plotted as a function of time. On the left column, shown
are the systems with native GM1, and on the right, are the data for BODIPY-
labelled GM1 systems. The first and the third row show results for the lo
systems, while the rest describe the results for the ld systems. Angles are
described in more detail in the text.
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6.4 Membrane Properties
In order to investigate the binding of cholera toxin to different lipid bilayer composi-
tions, it is important to understand the properties of these bilayers. Lots of different
quantities were calculated during this study. However, only the most relevant results
are presented in this thesis.
6.4.1 Order Parameter
The order parameter is a commonly used quantity to describe the order-disorder
transition of alloys or other materials [208]. Furthermore, it can be used to describe
the long-range order in structural or thermodynamic properties. Thus, the order
parameter is more used to get information about long carbon chains in a biological
environment, such as lipid tails.
In this study, the order parameter was calculated for one chain of SSM, DOPC,
GM1, and GM1-b lipids by using the GROMACS tool g_order. In general, the order
parameter can vary between 1 and −1/2. One means full order along the interface
normal, −1/2 the full order perpendicular to the normal, and zero corresbonds to an
isotropic (random) orientation.
The deuterium order parameter (Scd) [209] was calculated for both the native
GM1 and GM1-b. The results are shown in Fig. 6.8. As can be seen, Scd of GM1
and GM1-b is higher in the membrane consisting of cholesterol and SSM compared
to the membrane consisting of DOPC, which means that the tails are more ordered
in the lipid bilayer comprised of cholesterol and SSM. By comparing native GM1 and
GM1-b with each other, the BODIPY probe decreases the order of the tail. As can
be seen from Fig. 6.9, the BODIPY fluorophore does not only make the GM1 tail
more disordered but also induces order in the tails of the surrounding lipids.
6.4.2 Area per Lipid
In order to get more understanding of the geometry of lipids discussed in section 6.3,
the area per lipid is a relevant quantity to be investigated. In this study, the area per
lipid was calculated for each system in a very simple manner. First, the area of the
system in the xy-plane (membrane plane) was calculated at every time step by using
the GROMACS tool g_traj. Secondly, the area was divided by half the number of
lipids, which is 240 in our systems. Results of the calculation are given in Table 6.4.
In section 6.3 it was noticed that in the lo phase the head group of GM1 is more
constrained when compared to the ld phase. Area per lipid calculations can explain
this because the area per lipid is much smaller in the lo phase than in the ld phase,
as there is less space for the head group of GM1 to move in the liquid-ordered phase.
Although the lipid packing is more dense within the membrane in the lo phase,
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Figure 6.8: On the left is given the deuterium order parameter (Scd) for the tail of GM1,
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on the right is shown the Scd for the tail of SSM. Different colours represent
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: GM1-b.
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cholesterol molecules have a very small head group, which gives more space for the
other lipids in the head group area to move.
Table 6.4: Area per lipid during the 300–500 ns interval in each system.
Simulated system Area per lipid (nm2)
Ld/GM1 0.621 ± 0.005
Ld/GM1-b 0.626 ± 0.007
Lo/GM1 0.424 ± 0.002
Lo/GM1-b 0.436 ± 0.002
6.4.3 Density Profiles
In addition to the order parameter and the area per lipid, the thickness of the
membrane is also a commonly used quantity to analyse membrane properties. For
this purpose, the GROMACS tool g_density was used. The density profiles were
calculated for the phosphate group in the headgroup of either DOPC or SSM in the
ld and lo phases, respectively, and for the two residues in the head group of GM1:
the galactose group in the tip of the forefinger and the other galactose group. In the
calculations, the number of bins was selected to be 50.
As can be seen from Fig. 6.10, the addition of the BODIPY fluorophore into the
tail of GM1 causes thinning of the membrane. This partly goes hand in hand with
the order parameter: if the order of the tail is higher, the tail is more ordered and
therefore the thickness of the membrane increases. Because BODIPY makes the tails
more disordered, the effect on membrane thickness is also more significant in the lo
phase.
6.4.4 Electrostatic Potential of the Membranes
In addition to the density profiles of the lipids, the distribution of ions in water
was calculated. A remarkable difference in the head group region of bilayers can be
noticed when the ld and lo phases are compared with each other. By looking at the
graphs, sodium ions are located deeper within the membrane in the liquid-ordered
phase. If we take into account the fact that the membrane is also thicker in the
liquid-ordered phase, this highlights the difference even more in this sense. In the case
of the liquid-ordered phase, two different peaks of sodium ions can be seen at around
2.2 nm and 3.5 nm from the bilayer center. These peaks show that the membranes
attract the sodium ions. In contrast, in the liquid-disordered phase the ions are more
likely in the water phase and they are not so attracted by the membrane.
To get a better understanding of the effect of ions, the electrostatic potential
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Figure 6.10: Left: normalised density profiles of two galactose residues of GM1 head
group and a phosphate group of DOPC lipid in the ld phase. Right: the
same galactose groups from the GM1 head group and a phosphate group
from SSM are shown for the systems in the lo phase. The galactose group
in the tip of the forefinger is coloured as and the other galactose group
as . Phosphate groups are coloured as . The head groups of GM1
and GM1-b are shown in both pictures with the colors corresponding to the
density profiles of GM1 and GM1-b.
was calculated with the GROMACS tool g_potential along the membrane normal.
As can be seen from Fig. 6.11, the potential is rather different in the head group
area when comparing the systems with different lipid packing. As was in the case
of density of sodium ions, two different peaks can also be seen in the electrostatic
potential of the liquid-ordered phase. Most of the CTB residues which were noticed
to form hydrogen bonds with GM1 molecules have positively charged side chains. By
following the Coulomb interaction, the positively charged amino acid has a repulsive
interaction with the surface of the membrane if there are lots of positively charged
sodium ions. Therefore, these changes can have a large effect on the accessibility of
CT to the GM1 head group.
6.5 Liquid-disordered and Liquid-ordered Phases
This thesis does not include any experimental data although this is an ongoing project
done in collaboration with an experimental group. They have observed that the
lipid packing changes continuously instead of changing rapidly, for example from the
liquid-disordered phase to the liquid-ordered phase (unpublished data). Moreover, it
was previously noticed that the CTB binds more likely into the lipid bilayer in the
liquid-disordered phase [210]. One of our challenges was to unravel the question of
why the binding is different when the lipid packing changes.
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Figure 6.11: Left, density profiles for sodium ions in each system. Right, the electrostatic
potential of each membrane. Different colours represent different membrane
as: : ld with GM1, : lo with GM1, : ld with GM1-b and : lo
with GM1-b.
By following the results presented in this chapter, we can present a few explanations
for the differences in binding. First, we noticed that our model membranes follow the
basic idea of liquid-disordered and liquid-ordered phases: the membrane consisting
of DOPC was noticed to be much more disordered than the membrane consisting of
a 1:1 mixture of cholesterol and SSM. The membrane thickness was also noticed to
change. Secondly, the GM1 lipids in the liquid-ordered phase were noticed to have
more restricted structures, which may affect binding: if the geometry of the GM1
head group is favorable for the binding in one of the most probable positions (see
Fig. 6.6), then the binding may occur. On the contrary, if the needed orientation
for the binding is not one of the noticed orientations, then the probability for the
binding decreases. Finally, the membrane in the liquid-ordered phase was noticed to
attract more sodium ions into the head group area comparing to the membrane in
liquid-disordered phase, even though the head groups of lipids were the same (PC)
in all the membranes. Due to the difference in the amount of ions, the electrostatic
potential of the membrane was noticed to change dramatically. If we take into
account that most of the residues in CTB, which form hydrogen bonds with GM1
molecules, involve positively charged side chains, the long-range interaction between
these residues and the surface of the membrane is not as attractive as in the case
of the liquid-disordered phase, where the sodium ions are more likely in the water
phase.
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6.6 Effect of BODIPY Fluorophore
The same experimental team has used not only the native GM1 molecules, but also
the BODIPY labelled GM1 molecules in their studies [210]. In order to understand
the different behaviour of the native and the modified GM1 molecule, it was relevant
to understand how the fluorescent probe affects the membrane properties, and thus
the binding of cholera toxin.
As mentioned previously, the BODIPY label was noticed to change the properties
of the membrane into the liquid-disordered phase: the order of the lipid tails was
noticed to decrease, and therefore the membrane thickness was noticed to be smaller.
Although the binding of CT was speculated to be more favorable into the liquid-
disordered membrane, the affinity of the binding of CT was not noticed to be better
for the GM1-b lipids, although they disorder the membrane.
When changing from ld to lo, the average of the calculated angles were noticed to
remain approximately the same. Instead, when GM1 was labelled, its thumb was
observed to change its orientation. As the binding was proposed to mimic GM1
taking a grip of CTB by pinching it, the change in the orientation of one of the
fingers may play a major role in the binding. The electrostatic potential of the
membrane was found to remain approximately the same when GM1 was labelled.
Thus, it most likely does not affect the binding via changing electrostatic potential
of the membrane. Therefore, labelling of GM1 with the BODIPY probe influences
strictly the geometrical properties of the GM1 head group and thus affects the specific
receptor–ligand fit.
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7. CONCLUSIONS
The aim of this Thesis was to use atomistic molecular dynamics simulations to
study how modifications in lipid composition of a protein-free membrane affect the
binding of cholera toxin with a membrane. The idea for this study originate from
experimental studies, which have shown that lipid packing varies continuously instead
of being characterized by sharp borders between different phases [211]. Furthermore,
by using fluorescence spectroscopy for synthetic Giant Unilamellar Vesicles (GUVs)
and cell-derived Giant Plasma Membrane Vesicles (GPMVs) it has been shown that
cholera toxin binds intensively into the ld parts of the vesicles and with a lower
affinity to a membrane in the lo phase [210]. The first goal was to explain why the
binding differs when the lipid packing of the membrane is changed.
Two systems were simulated for this purpose: GM1-b in the ld phase consisting of
DOPC, and GM1-b in the lo phase, consisting of cholesterol and SSM. The results
showed that the orientation of the head group of GM1-b changes depending on the
lipid environment around the lipid. In the liquid-ordered phase the head group of
GM1-b was noticed to have a more rigid structure, which constraints the movements
of the head group compared to the same lipids in the ld phase. The area per lipid
calculations showed clearly that there is more space for the head groups to move in
the ld phase, which confirms the result of different orientations of the head group.
In addition to geometrical properties of GM1-b, the electrostatic potential of the
membrane was observed to change significantly. The membrane in the lo phase was
shown to attract sodium ions, not only deeper into the membrane, but also in the
head group region while the head groups of the lipids were the same in both phases.
Due to the different distribution of sodium ions in the head group region, the profiles
of the electrostatic potential across the membrane differed in the ld and lo phases.
Based on the calculations of hydrogen bonds between GM1 and all the residues of
cholera toxin, the amino acids with positively charged side chains were found to play
a major role in the binding process. Due to a change in the electrostatic properties
of the membrane, the binding of cholera toxin was found to be the liquid-ordered
phase.
Additionally, it has been shown experimentally that there is also a difference in
the toxin binding depending on the structure of GM1 [210]. The experiments used
not only the BODIPY-labelled GM1, which can be detected by using fluorescence
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spectroscopy, but also the native GM1. To elucidate this point, two additional lipid
bilayers were created by modifying the two existing lipid bilayers described before in
a way that all the GM1-b molecules were transformed into the native GM1. As a
result, the thumb moiety of the head group of GM1 bent towards the bulk water
while the GM1 was labelled with the BODIPY fluorophore. Due to the fact that
CTB is a pentameric protein, a geometrical fit is essential for its interactions with
GM1. It seems evident that as the orientation of the head group of GM1 is changed,
the specific receptor–ligand fit is interfered, and thus the affinity of CTB towards
the GM1-b is not as favored as towards the native GM1.
Further studies could be focused on getting more details of the interactions between
cholera toxin and various membranes. So far, only one system for each case has
been simulated. To be sure that the most important residues of the CTB in the
binding process were correctly identified, and to be certain about the most attractive
lipids to the CTB, replicas of these systems are needed. Furthermore, it could be
unambiguous to show free energy profiles for the binding process in each simulated
system, for example by using the umbrella sampling method [212]. However, this
approach has some problems in this case. First of all, the initial structure for proper
binding is needed which may require much longer simulation times than those used in
this study. Secondly, the umbrella sampling windows itself are heavy to calculate for
systems of this size — if it could be done for one system, they would still have to be
repeated for four different systems to compare the binding into different lipid bilayers.
A more realistic approach to compare free energy profiles of the toxin binding to
different lipid bilayers would be to calculate the free energy profile for just one amino
acid at a time. This approach is also a bit problematic though. First, the important
amino acids should be known, and secondly, the simulation of just one amino acid is
not trivial.
Although some features related to the binding remain unknown, a few striking
discoveries were made based on the MD simulations. In particular, appropriate
reasons to the observed differences in toxin binding to various lipid bilayers have
been found.
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